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Introduction 
Adenoma detection rate (ADR) is an established quality marker in 
colonoscopy. Significant variability in ADR exists. Withdrawal time of ≥ 6 
minutes; Buscopan use; position change and rectal retroflexion have been 
shown to improve lesion detection. We evaluated the feasibility and clinical 
outcome of implementing these measures, as a „bundle‟, into routine practice 
to improve ADR. Factors influencing uptake were evaluated in a qualitative 
study. 
 
Methodology 
Twelve units participated. All nominated a lead colonoscopist and nurse. 
Implementation combined central training, local leadership, feedback and 
continuous central support. The 3 months prior to implementation was 
compared to a 9 month period after. Colonoscopists performing ≥ 25 
procedures during the baseline period were ranked in quartiles by ADR. 
Buscopan use was used as a surrogate marker for uptake. Changes were 
evaluated using a corrected Chi Squared test. For the qualitative study, units 
and individuals were purposively sampled to ensure a range of units were 
included. Semi-structured interviews were conducted until saturation was 
reached. Data were evaluated using thematic analysis. 
 
Results 
Global and quartile analyses comprised data from 118 and 68 colonoscopists 
performing 17, 508 and 14,193 procedures respectively. There was a 
significant increase in Buscopan use globally (15.8% vs. 54.4%, p<0.001) and 
in each quartile. The ADR also increased significantly globally (16.0% vs. 
18.1%, p=0.002), with a significant reduction in variation. Interviews were 
conducted with 8 lead and 3 non-lead colonoscopists and 1 lead nurse. 
Increased emphasis on examination time, awareness of ADR as a quality 
marker and empowerment of endoscopy nurses to encourage the use of 
quality measures were positive outcomes of the intervention. Challenges 
included difficulty in arranging set up meetings and engaging certain speciality 
groups. 
 
Discussion 
This evidence based educational intervention resulted in a significant change 
in behaviour, evidenced by increased Buscopan use. A significant increase in 
the global ADR and reduction in variation between quartiles was observed. 
Other positive outcomes included increased awareness of colonoscopy 
quality and empowerment of endoscopy nurses to promote quality measures. 
This study demonstrates that simple interventions can significantly change 
practice and improve quality. The timing of meetings and strategies to engage 
speciality groups are important. 
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Introduction 
Colorectal cancer is a major cause of premature death in the United Kingdom 
(UK) and is the second most common cause of cancer related death. The 
majority of sporadic colorectal cancers are thought to develop from benign 
colorectal adenomas. The detection and subsequent removal of colorectal 
adenomas has been shown to reduce the subsequent risk of developing 
colorectal cancers. 
 
The starting point of this thesis is that the quality of colonoscopy across the 
UK is not uniform and that unacceptable variance exists between 
colonoscopists, as evidenced by a British Society of Gastroenterology (BSG) 
colonoscopy audit published in 2004. This clinical audit referred to caecal 
intubation rates (CIR) but there is also ample evidence that adenoma 
detection rates (ADR) also show unacceptable variation across the country 
and between individual colonoscopists. 
 
Colonoscopy is considered the „gold standard‟ investigation for the detection 
of colorectal adenomas and also allows their removal. Therefore, high quality 
colonoscopy has the potential to reduce the incidence of colorectal cancer 
and forms the backbone of colorectal cancer screening in most national 
programmes.  
 
Maintaining and improving the quality of colonoscopy is vital to allow optimal 
detection of colorectal adenomas. A high quality colonoscopy must consist of 
both a complete and thorough examination of the colonic mucosa. The BSG 
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audit of colonoscopy practice published in 2004 demonstrated that completion 
rates were well below the nationally recommended standards. Following this 
report, significant investment was put into improving this aspect of 
colonoscopy through more thorough monitoring and improvements in training. 
These changes to colonoscopy training did not take into account the issue of 
training that may be required for independent colonoscopists who were 
underperforming. 
 
The ADR, defined as the number of procedures in which one or more 
adenomas are detected, has been recommended as a surrogate marker for a 
thorough examination by many national societies. A recent study also 
demonstrated that patients undergoing colonoscopy by colonoscopists with a 
lower ADR were at higher risk of developing an interval cancer. This study 
further supports the use of ADR as a quality marker in colonoscopy. Several 
studies, both UK and international, have demonstrated that a variation in 
adenoma detection, and therefore colonoscopy quality, continues to exist. It is 
crucial that efforts are made to improve ADR in order to maximise the 
potential of colonoscopy to reduce colorectal cancer incidence. 
 
Inspection of the colonic mucosa is performed primarily during the withdrawal 
phase of the colonoscopy. There are several measures that have been shown 
to improve adenoma detection by providing the optimal conditions for 
identifying such lesions. Whilst these measures are used by some 
colonoscopists, they are not used routinely by all. Therefore, it is possible that 
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the routine use of all these measures during colonoscopy withdrawal may 
improve adenoma detection and thereby the quality of colonoscopy. 
 
Implementing evidence into clinical practice can be challenging and frequently 
involves changing long held behaviours and practices. There has been much 
work investigating how best to undertake this process including identifying 
barriers to uptake and mechanisms for implementation in varied settings. 
Peter Pronovost outlined a model for implementing a „bundle‟ of interventions 
shown to reduce the number of catheter-related bloodstream infections in an 
intensive care setting. This combined central training, locally led 
implementation and ongoing central support. It is feasible that this model 
could be used to implement clinical evidence into colonoscopy practice. 
 
The Quality Improvement in Colonoscopy (QIC) study was a region wide 
service improvement study that evaluated the feasibility of implementing a 
„bundle‟ of evidenced based measures into routine colonoscopy practice with 
the aim of improving ADR.  
 
Chapter one details the epidemiology of colorectal adenomas and colorectal 
cancer including early detection, prevention and the role of colonoscopy in 
achieving these aims. The importance of high quality colonoscopy and the 
metrics that are used to measure performance is further discussed.  
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Chapter two presents how current standards in the study region were 
evaluated and how these data provided a baseline against which the study 
intervention could subsequently be measured.  
 
In chapter three, measures that have been shown to improve quality in 
colonoscopy, through improving lesion detection, will be reviewed and the 
evidence supporting each measure discussed. The potential problems of 
implementing evidence into clinical practice will also be reviewed, together 
with mechanisms that have been shown to overcome these issues in different 
clinical settings.  
 
In chapter four, the model selected for this study is also discussed including 
how barriers were identified and solutions developed together. The results of 
implementation are presented along with how they compare to other 
implementation programmes.  
 
Chapter five outlines how implementation of the „bundle‟ affected ADR across 
the region as a whole as well as in relation to individual colonoscopists ranked 
in quartiles based on their baseline ADR and, importantly, the affect on 
variation.  
 
The factors influencing uptake of the „bundle‟ were studied in a qualitative 
study the outcomes of which are presented in chapter six, including how they 
can inform future service improvement initiatives.  
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The final chapter summarises this thesis, discusses the limitations of the work 
and the conclusions that can be drawn from this study. The further work that is 
required following the study is also outlined. 
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Chapter One: Colorectal Cancer - A preventable condition 
1.1. Introduction: Epidemiology of Colorectal Cancer 
Colorectal cancer is a common disorder in the United Kingdom (UK). It is the 
third most common cancer overall with an annual incidence of 30 to 40,000 
cases. It is the second most common cause of cancer related mortality 
resulting in approximately 16,000 deaths per year. (1) It affects men more 
commonly than women, the respective life-time risk being approximately 1 in 
16 and 1 in 20 among men and women. It also occurs more frequently with 
increasing age with 80% of cases diagnosed in those aged 60 years and 
above. (1) 
 
Colorectal cancer affects the left side of the colon more frequently with 
approximately 75% of cancers at or distal to the splenic flexure. (1) This may 
lead to bowel symptoms such as rectal bleeding, change in bowel habit and 
abdominal pain. (2) Cancers that occur proximal to the splenic flexure tend to 
cause fewer symptoms in the early stages and their presence may only be 
suspected following abnormal blood tests such as iron deficiency anaemia. (2) 
Currently, the majority of colorectal cancers come to the attention of medical 
services following the development of bowel symptoms or abnormal blood 
tests. (3) Unfortunately the presence and duration of such symptoms is 
associated with a more advanced cancer stage at presentation. (2) 
Individuals, especially those of advancing age, are therefore strongly 
encouraged to seek medical advice promptly following the development of 
new bowel symptoms. 
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1.2. Staging and Prognosis of Colorectal Cancer 
Colorectal cancer is most commonly detected during colonoscopy. Following 
diagnosis, full staging must be performed in order to allow appropriate clinical 
decision making regarding treatment. The staging systems used for colorectal 
cancer staging include the tumour, node, metastases (TNM) staging system 
(4), which is also used in other cancers, and the Dukes staging system which 
is specific to colorectal cancer. The Dukes staging system was first described 
in 1932 and its modified version is still widely used. Both systems are based 
on extent of local tumour invasion, the presence of lymph node involvement 
and distant metastases. Table 1 describes each system and how they 
correlate with one another. 
 
Table 1: Summary of TNM and Dukes staging systems 
TNM 
 
Modified 
Dukes stage 
Stage 0 Carcinoma in situ 
A 
 
Stage I 
 
 
No nodal involvement, no distant metastasis 
Tumour invades submucosa (T1, N0, M0) 
Tumour invades muscularis propria (T2, N0, M0) 
Stage II 
 
 
No nodal involvement, no distant metastasis 
Tumour invades into subserosa (T3, N0, M0) 
Tumour invades into other organs (T4, N0, M0) 
B 
 
Stage III 
 
 
Nodal involvement, no distant metastasis 
1 to 3 regional lymph nodes involved (any T, N1, M0) 
4 or more regional lymph nodes involved (Any T, N2, 
M0) 
C 
 
Stage IV Distant metastasis (any T, any N, M1) D 
 
In addition to aiding clinical decision making, the cancer stage allows 
clinicians to estimate prognosis. As may be expected, the more advanced the 
cancer stage, the poorer the likely outcome.  
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Table 2 shows the approximate 5-year survival that can be expected for each 
Dukes stage. (5) 
 
Table 2: Dukes stage and expected 5-year survival 
Dukes Stage 5-year survival (%) 
A 90 
B 60 
C 30 
D 10 
 
Table 3 summarises the Dukes stage at presentation for 28,112 patients from 
the UK 2011 National Bowel Cancer Audit Report. This highlights the 
relatively large proportion of individuals that continue to present with 
advanced (Dukes C and D) disease. (6) 
 
Table 3: Dukes stage at diagnosis in symptomatic patients from the UK 
National Bowel Cancer Audit Report 2011 (6) 
Dukes Stage Proportion of patients (%) 
N = 28,112 
A 12.4 
B 23.8 
C 20.4 
D 18.6 
Unknown 24.6 
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These data demonstrate that it is clearly preferable to detect cancers at an 
earlier stage. The National Bowel Cancer Screening Programme (BCSP) 
began to roll-out in England and Wales in 2006 with the primary aim of 
detecting colorectal cancers at an earlier stage. (7) Individuals aged between 
60 to 74 years (age range extended from 69 years to 74 years from January 
2010) are currently invited to take part in biennial postal faecal occult blood 
testing (FOBt) and those who test positive are considered for colonoscopy. 
Colonoscopists are eligible to become BCSP colonoscopists only if they have 
performed >1000 colonoscopies and perform colonoscopy safely and to a 
high technical standard. They must also undertake and pass a rigorous 
assessment process. Early published data has demonstrated that the BCSP 
has been successful in detecting cancer at an earlier stage when compared 
with the non-screening population. (8, 9) 
 
In the years leading up to the introduction of the BCSP, colonoscopy 
performance in the UK was variable. This was highlighted by the first British 
Society of Gastroenterology (BSG) audit performed in 1999, the results of 
which were published in 2004. (10) This was of particular relevance as the 
then upcoming introduction of the BCSP could potentially affect the quality of 
colonoscopy in the symptomatic service both due to the increased demand 
and the more highly performing colonoscopists being potentially less able to 
perform diagnostic procedures due to BCSP commitments. This, in part, led to 
the government investing significantly in a programme of improvement in 
colonoscopy led by the Joint Advisory Group (JAG) for gastrointestinal 
endoscopy the outcome of which will be discussed below. 
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1.3. Colorectal adenomas and their management: the role of 
colonoscopy in cancer prevention 
Whilst detecting colorectal cancer at an earlier stage has the potential to 
improve prognosis, its prevention would be preferable. It is widely accepted 
that colorectal cancers develop from colorectal adenomas. The progression of 
adenomas to cancer is known as the adenoma-carcinoma sequence.   
 
Sporadic colorectal adenomas are thought to develop due to a combination of 
genetic and environmental factors. It is thought that multiple events are 
required to encourage progression along the adenoma-carcinoma sequence. 
This process is slow and amenable to intervention.  (11) 
 
Figure 1 summarises some of the genetic alterations thought to contribute at 
various stages of progression. (11) 
 
Figure 1: Genetic changes at respective stages of the adenoma-carcinoma 
sequence (used with permission from Oxford Journals) 
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Factors associated with the probability of developing adenomas and 
colorectal cancers can be considered as modifiable and non-modifiable. 
Known non-modifiable factors include age, gender and family history 
(genetics). Several modifiable factors are recognised, including cigarette 
smoking, alcohol consumption, dietary intake and body mass index (BMI). 
(12-14) Co-existing medical disorders, such as inflammatory bowel disease, 
diabetes mellitus and acromegaly also influence the likelihood of developing 
colorectal adenomas and cancers. (13, 15, 16) 
 
Whilst life style modification and optimal treatment of medical conditions is 
advisable to reduce the risk of colorectal adenoma formation, its efficacy has 
yet to be demonstrated. Currently, the most effective way preventing the 
progression of adenomas to cancer is their removal at colonoscopy and 
subsequent colonoscopic surveillance of “at risk” individuals, a strategy that is 
recommended by several national societies. (17, 18) There is a growing body 
of evidence demonstrating the effectiveness of this strategy with several 
studies showing the incidence of colorectal cancer amongst individuals 
undergoing complete colonoscopy and removal of detected adenomas was 
significantly lower than that in matched cohorts. (19, 20) 
 
There has also been much work studying the association between the number 
and size of colorectal adenomas present and the risk of developing significant 
lesions in the future. These studies have demonstrated a clear association 
between both the number and size of the detected adenomas and the 
likelihood of individuals developing further clinically significant adenomas. (21) 
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In addition, it has been demonstrated that small adenomas in sufficient 
numbers are associated with the development of future adenomas and 
cancer. The BSG guidelines on colorectal adenoma surveillance incorporate 
this evidence and is summarised in Figure 2. (22) Individuals are classified 
into three risk groups depending on the number and size of the adenomas 
detected and future colonoscopic surveillance recommended based on the 
level of risk. The importance of detecting and removing colorectal adenomas 
both to reduce the risk of colorectal cancer and to plan future colonoscopic 
surveillance is highlighted by these guidelines with high quality colonoscopy 
an integral part of this process. 
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Figure 2: BSG guidance regarding adenoma surveillance (reproduced with 
permission from Gut)  (22)  
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1.4. Colonoscopy: Room for Improvement 
1.4.1. Quality Markers in Colonoscopy 
Colonoscopy is currently the „gold standard‟ investigation for the detection of 
colonic lesions. In addition to providing diagnostic information, colonoscopy 
allows sampling of colonic tissue and therapeutic procedures to be performed, 
including the removal of potentially premalignant colorectal adenomas. 
 
When performing a colonoscopy it is vital to perform a complete examination. 
A colonoscopic examination is considered to be complete if the colonoscope 
is successfully passed into the caecum, known as caecal intubation, (17, 18) 
or terminal ileum (TI). All colonoscopists must record and report a complete 
examination of the colon and ideally support this with photographic 
documentation of caecal landmarks. The only reliable landmarks of 
completion are visualisation of the ileocaecal valve (ICV) or TI, although 
visualisation of the appendiceal orifice or tri-radiate folds is often accepted. 
The completion or caecal intubation rate (CIR) is considered a marker of 
quality in colonoscopy. Current UK guidelines from the Joint Advisory Group 
(JAG) for gastrointestinal endoscopy state that all colonoscopists should have 
a CIR of at least 90%. (17) 
 
In addition to a complete examination, it is also vital that the colonic mucosa is 
examined thoroughly in order to maximise the detection of abnormalities. It is 
not currently possible to measure how thoroughly a colonoscopist visualises 
the mucosa directly.  A surrogate marker for this is the frequency with which 
colorectal adenomas are detected. The most widely accepted measure is the 
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adenoma detection rate (ADR) defined as the number of procedures in which 
one or more adenomas are detected. (17, 18, 23) In the UK, the JAG states 
that a colonoscopist should have an ADR of at least 10%. (17) 
 
There has been additional emphasis on quality in colonoscopy following the 
recent introduction of the BCSP. In order to practice as a BSCP 
colonoscopist, an individual must have performed at least 1000 colonoscopies 
and have a CIR of ≥90% and ADR of ≥20% in the preceding 12 months in the 
symptomatic services. Following accreditation, colonoscopists must maintain 
a CIR of ≥90% and an ADR of ≥35% in the BCSP population. (24) In the 
Netherlands, an ADR of at least 20% in the symptomatic services is also 
required for colonoscopists to be eligible for screening. (25) These criteria 
suggest that the minimum ADR of 10% required in the symptomatic services 
in the UK is too low and that colonoscopists should be aiming for a 
significantly higher figure. It also suggests that many colonoscopists fail to 
adequately visualise the entire colon to a satisfactory standard. 
 
The use of ADR as a quality marker was further supported by a recently 
published study of data from the Polish bowel cancer screening programme. 
(26) This study examined the relationship between the CIR, ADR and interval 
colorectal cancers. Interval cancer was defined as colorectal cancers that 
were diagnosed between the time of screening colonoscopy and the 
scheduled time of surveillance colonoscopy, according to the 
recommendations of the U.S. Multi-society Task Force on Colorectal Cancer 
and the American Cancer Society. (27) Individuals were eligible for the 
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programme if they were 50 to 66 years of age and in good health and 
colorectal cancer was not suspected clinically. Individuals aged 40 to 49 were 
eligible if they had a family history of any type of cancer. The presence of any 
symptoms suggestive of cancer was grounds for exclusion from the 
programme. It was demonstrated that colonoscopists with an ADR less than 
20% had a hazard ratio (HR) for interval cancer that was ten times higher than 
colonoscopists with an ADR of greater than 20%. The most likely explanation 
for this is that colonoscopists with a lower ADR may have missed significant 
lesions that subsequently developed into cancers. There was no association 
between CIR and interval cancers as the rates were globally high. The results 
of this work support the use of ADR as a surrogate marker of a thorough 
colonic examination. We must acknowledge that the study was performed 
within a screening population selected by age and increased risk due to a 
positive family history and so it is unclear whether the 20% figure is 
generalisable to an unselected symptomatic population. However, the findings 
do suggest that a higher minimum ADR should be aimed for, particularly in 
patients above the age of 50 years.   
 
1.4.2. Variability in Colonoscopy Quality 
Colonoscopy is widely available in the UK and demand for the procedure is 
increasing both in the diagnostic services, for which the majority are 
performed, and following the introduction of bowel cancer screening. (28) Until 
recently, there was considerable variation in the quality of colonoscopy in the 
UK. This was highlighted by Bowles et al who performed an audit of 
colonoscopy practice in 68 endoscopy units in 1999. (10) It was reported that 
 34 
 
overall completion rate was as low as 76.9%. If only visualisation of the ICV or 
TI was considered acceptable for a colonoscopy to be considered complete, 
this fell to 56.9%. This is clearly well below recommended guidelines for 
acceptable completion rates. Polyps were detected in 22.5% of procedures 
however ADRs of the participating colonoscopists were not reported in this 
audit. This work prompted significant changes in colonoscopy training and 
monitoring of quality as mentioned above. The changes in training were 
centrally funded. This was approximately £497,000 over three years in the 
northern region alone. This led to the development of endoscopy teaching 
centres which ran programmes, including hands on training for those training 
in endoscopy initially, and training for those teaching endoscopy more 
recently. It must be borne in mind that the majority of current colonoscopists 
remain out with this change in training philosophy.   
 
Several studies have demonstrated variability in polyp and adenoma detection 
between colonoscopists. One systematic review looked at six studies in which 
participants underwent two same-day (tandem) colonoscopies. (29) Polyps 
detected at the initial colonoscopy were removed. Miss rates were reported as 
the number of polyps seen only on the second colonoscopy expressed as a 
percentage of the total number of polyps detected. Results were given for 
polyps of all sizes and also for adenomas only of the following size groups: 1-
5mm; 5-10mm; > 10mm. The miss rates for all polyps and all adenomas were 
21% and 22% respectively. As may be expected larger lesions are missed 
less frequently, 2% for adenomas >10mm, with higher miss rates for smaller 
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adenomas, 13% for adenomas between 5-10mm and 26% for those between 
1-5mm.  
 
A further study which examined the association between mean withdrawal 
time (MWT) and adenoma detection demonstrated a 10 fold variation in the 
adenoma detection. (30) In this study, adenoma detection was expressed as 
ADR and the number of adenomas per subject screened which ranged from 
0.10 to 1.05. 
 
1.4.3. Colonoscopy withdrawal technique as a factor contributing to 
variable adenoma detection rates 
The variability in adenoma detection, and therefore quality, has led to much 
work examining the factors that may contribute to this problem. Whilst there 
are likely to be many contributing factors, the colonoscopic technique used to 
view the colonic mucosa is undoubtedly a major one. The colon is examined 
primarily during the withdrawal phase of the procedure and there has been 
much work looking at the components of withdrawal technique and how this 
influences adenoma detection. The presence of variable technique and its 
influence on adenoma detection was demonstrated in a study performed by 
Rex et al. (31) In this study, two colonoscopists of similar experience with 
known different adenoma miss rates had ten colonoscopies video recorded. 
The withdrawal phase of the procedure was assessed by four experts with 
scores given for the following criteria: adequacy of time spent viewing; 
adequacy of luminal distension; cleaning and suctioning; examining the 
proximal sides of flexures, folds and valves. The colonoscopist with the higher 
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miss rate received consistently and significantly poorer scores for all four 
criteria. This suggests that improving colonoscopy withdrawal technique is 
one way of improving adenoma detection. Lee at al demonstrated similar 
findings in their study of 11 screening colonoscopists. (32) In addition to 
withdrawal technique, introducing measures to improve luminal distension and 
increase visible mucosal area also has the potential to improve mucosal 
examination as measured by adenoma detection during colonoscopy. 
 
In summary, colorectal cancer continues to cause significant morbidity and 
mortality in the UK. The condition is potentially preventable by high quality 
colonoscopy aimed at detecting and removing colorectal adenomas. There is 
evidence that the quality of colonoscopy, including mucosal examination, is 
variable. Kaminski et al demonstrated the potential consequences of this 
variability in ADR, observing an increase in the risk of interval cancers among 
patients colonoscoped by endoscopists with a low ADR. The current standard 
of colonoscopy within the study region was evaluated to understand the 
variability in ADR prior to the study intervention and is presented in the next 
chapter. 
 
 
 
 
 
 
 
 37 
 
Chapter Two: Evaluating colonoscopist performance 
within the study region and the use of funnel plots as a 
method of analysis 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 38 
 
Chapter Two: Evaluating colonoscopist performance within the study region 
and the use of funnel plots as a method of analysis 
 
This chapter details the quality of colonoscopy within the study region and 
how this affected subsequent analysis of study observations. 
 
2.1. Introduction: Why the Northern Region Endoscopy Group? 
The northern region is one of the largest health regions geographically in 
England covering an area stretching from the Scottish Borders to North 
Yorkshire and across to the western border of County Durham and northern 
Cumbria. Hospitals in the region serve a population of approximately 3.5 
million people. The region has well developed endoscopy services and was at 
the forefront of developing and implementing the recent BSG and JAG led 
quality improvement initiative in endoscopy programme. This had improving 
colonoscopy completion rates, sedation practice and training among its 
primary aims. It was also the first region to have BCSP coverage across its 
entirety. (33) Research is actively encouraged in all units, however, most are 
too small to perform independent projects.  
 
The northern region endoscopy group (NREG) is a collaborative research 
network formed in 2007 to allow high quality, region wide research, audit and 
service improvement work. (33) All 17 endoscopy units in the nine NHS Trusts 
within the region are members of NREG, representing all 300 endoscopists. 
There are approximately 100,000 endoscopic procedures performed in the 
region each year, comprising approximately 45,000 upper gastrointestinal 
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endoscopies, 28,000 colonoscopies, 18,000 flexible sigmoidoscopies and 
3000 ERCPs (endoscopic retrograde cholangiopancreatography). 
Membership of NREG is open to all with an interest in endoscopic research. 
Each unit is asked to nominate a lead clinician to act as a representative and 
to disseminate information back to their unit. All units have equal voting rights 
within NREG. Meetings occur quarterly, coordinated by the chair, during which 
new research proposals are put forward and developed along with updates on 
projects that are underway. Each project has an individual steering group, 
overseen by the NREG committee. 
 
The success and supportive infrastructure of NREG meant that it was an ideal 
setting in which to perform this quality improvement project. All member units 
were invited to participate and those who accepted were asked to nominate a 
lead colonoscopist (who could be different from their NREG link person) and a 
lead endoscopy nurse. Their role was to run and promote the study locally, in 
addition to being a point of contact for the central study team. 
 
2.2. Methods 
2.2.1. Data collection, transfer and storage 
Twelve endoscopy units agreed to participate in the study. Prior to the 
collection of study data, the project was registered at all units through the 
appropriate departments. Caldicott approval was sought and gained for 
access to patient information and data collection including the transfer of data 
outside of the unit when required. Transferred data did not include patient 
identifiable information. Each colonoscopist was given a study code number 
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so that their name need not be used on transferred data. A data collection 
form was developed (Appendix A) onto which all data was transferred after 
appropriate cleaning. The data collected included: 
 
 Endoscopy Unit 
 Colonoscopist‟s code 
 Colonoscopist Grade 
 Total number of colonoscopies performed 
 Total number of completed colonoscopies 
 Caecal intubation rate 
 Total number of procedures in which ≥ 1 polyp was detected 
 Polyp detection rate 
 Total number of procedures in which ≥ 1 adenoma was detected 
 Adenoma detection rate 
 Total number of patients in which Buscopan was used (discussed in 
chapter three) 
 Total number of male patients 
 Mean patient age 
 
For the calculation of ADR, the histological diagnosis is required. The majority 
of individuals charged with colonoscopy performance quality assurance do not 
routinely collect these data. The polyp detection rate (PDR), proportion of 
procedures in which at least one polyp is detected expressed as a 
percentage, is often used as an alternative as its calculation is simpler. 
Consequently, data on histological type of all polyps was collected through 
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manual interrogation of the pathology systems at each respective unit. Thus 
the histology results of all lesions thought to be polyps by the colonoscopists, 
based on their endoscopic appearance, were retrieved.  
 
Data on adverse events were also collected from each unit using their 
accepted reporting system. They were defined as those preventing 
completion of colonoscopy (excluding poor bowel preparation or technical 
failure) or resulting in unplanned hospital admission, prolongation of existing 
hospital stay, an unplanned interventional procedure or another medical 
consultation. (7) 
 
Data were stored on a password protected computer at South Tyneside 
Foundation Trust in accordance with trust protocol and the terms under which 
data were allowed to be transferred from each of the other participating trusts. 
 
2.2.2. Definitions 
The caecal intubation rate (CIR) was defined as the proportion of all 
colonoscopies performed in which caecal intubation was achieved expressed 
as a percentage.  
 
The adenoma detection rate (ADR) was defined as the proportion of 
procedures in which one or more adenomas were detected expressed as a 
percentage.  
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Buscopan use rate (BR) was defined as the proportion of procedures in which 
Buscopan was used expressed as a percentage. 
 
2.2.3. Data cleaning 
The monitoring of colonoscopy performance, including markers of 
colonoscopy performance and sedation practice, is mandatory. Each 
endoscopy unit must submit an annual report to the JAG regarding this and 
other areas of endoscopy performance. As a result, units have become 
reasonably accustomed to collecting this type of data. All of the units within 
NREG have electronic endoscopy reporting systems that can be used to 
extract colonoscopy related data. Whilst each unit had a mechanism for 
collecting performance data, they were different depending on the 
idiosyncrasies of the respective reporting system. The data extracted were 
also dependent of the quality of the reports entered by the colonoscopist. This 
was variable and has been shown in previous work. (34) The end result was 
that data was received in varying formats and quality requiring different 
degrees of cleaning. The systems in use were Endosoft in seven units, 
Unisoft in three units, Endoscribe in one unit and ADAM in one unit.  The lead 
colonoscopist for each unit was approached regarding data collection 
although in some cases this was delegated to a more appropriate person 
responsible for this type of data collection. Unisoft, Endoscribe and ADAM 
allow clinicians to access the audit facility of the programme, however, only 
information technology (IT) personnel have access to the audit facility of 
Endosoft. Issues encountered included the following: 
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 Confirming colonoscopies had taken place 
 Excluding incorrectly entered procedures e.g. gastroscopies and flexible 
sigmoidoscopies that had been entered as colonoscopies 
 Ensuring no double counting of procedures 
 Confirming polyp detection 
 Confirming Buscopan use 
 
After addressing these issues, histology results were retrieved and ADR and 
BR could be calculated. 
 
2.2.4. Evaluating performance data: Funnel plots as a method of analysis 
Quality assurance within the NHS is vital to ensure delivery of the best 
possible service. The monitoring and improvement of services can be 
challenging and requires a method that allows meaningful comparison 
between units and individuals that perform varying procedure numbers. 
Statistical process control (SPC) is one method used in many industrial 
processes to monitor the quality of their products. (35) In addition, SPC can 
identify processes that may be failing prior to the production of substandard 
goods. Recently, SPC methods have been used in a variety of clinical settings 
to monitor outcomes of their services including surgical procedures, 
percutaneuous coronary angiograms and trauma care. (36, 37) 
 
The use of funnel plots, as a graphical representation of performance data, is 
one such method. (35) In such graphs, the chosen performance measure is 
plotted (on the y axis) against case volume (on the x axis). Funnel plots 
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include upper and lower confidence limits, most commonly 95% +/- 99.8% 
limits, calculated relative to a reference standard or mean for the dataset. The 
confidence limits depict how much „common cause variation‟ would be 
expected for a given case volume. Falling outside the confidence limits would 
indicate „special cause variation‟ due to some other factor that may be internal 
or external to the process in question and may warrant further investigation. 
Therefore, this allows meaningful comparison of units and individuals that 
perform different procedure volumes, both with reference to established 
standards and to each other. 
 
In order to allow analysis of the baseline data, idealized funnel plots with 
upper and lower 95% CIs were created for CIR and ADR relative to the 
current recommended national standards and for global mean for ADR for the 
dataset.  
 
The colonoscopy data analysed included those from all colonoscopists 
performing procedures during a three month period (1st of October to 31st of 
December 2010) in the participating units. The prevalence of adenomas within 
the BCSP population has been shown to be higher than in the non-BCSP 
population. (38, 39) Therefore, the ADRs of colonoscopists that perform 
screening are higher than those who do not. It was not possible to reliably 
distinguish between procedures performed within the BCSP and those for the 
diagnosis of symptoms for each colonoscopist. As a result, performance data 
from colonoscopies performed by BCSP accredited colonoscopists were 
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included for the calculation of CIR (in order to more accurately reflect quality 
of this marker within the region) but were excluded from calculation of ADR. 
 
2.3. Results 
Overall, 129 colonoscopists were included for all stages of analysis including 
47 (36.4%) consultant gastroenterologists, 42 (32.6%) consultant surgeons, 
15 (11.6%) nurse endoscopists, 6 (4.7%) non-consultant grade staff, 18 
(14.0%) trainees and 1 (0.8%) geriatrician. The mean patient age was 60 
years (range of mean ages per colonoscopist 48 to 70 years) and 49% were 
male. 
 
Excluding BCSP colonoscopist data, 4748 colonoscopies were performed 
during the three month baseline period. The number of colonoscopies 
performed by each colonoscopist ranged from 1 to 143, the spread of which is 
shown in Figure 3. 
 
Caecal Intubation Rate (CIR) 
The global CIR including BCSP colonoscopists was 92.5% (CI 91.2-92.6). The 
CIR excluding BCSP colonoscopists was 91.5% (CI 90.5-92.5). The figures 
from BCSP colonoscopists are excluded from all subsequent results. Results 
per unit are shown in Table 4. A funnel plot showing each unit‟s CIR with 
respect to the national standard is shown in Figure 4. All units were above the 
lower 95% confidence limit. Three units achieved CIR‟s that were above the 
upper limit. 
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Figure 3: Summary of the number of colonoscopies performed per 
colonoscopist during the three month period 
 
 
 
A funnel plot for each colonoscopists CIR relative to the national standard is 
shown in Figure 5.  The majority were grouped around the national standard. 
Seventeen (13.2%) colonoscopists were above the upper limit and 1 (0.8%) 
below the lower limit. Thirty nine (30.2%) were below the national standard but 
above the lower limit. 
 
Adenoma Detection Rate (ADR) 
The global ADR was 15.9% (CI 14.9-17.0). ADRs per unit are summarised in 
Table 5. Funnel plots showing each unit‟s ADR with respect to the national 
standard and the global mean were plotted and are shown in Figure 6 and 
Figure 7 respectively.  All units met the national standard with 10 units 
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achieving ADRs above the upper limit. With respect to the global mean ADR, 
all but 1 unit were above the lower 95% limit. 
 
Funnel plots of each colonoscopist‟s ADR with respect to the national 
standards and the global mean are shown in Figure 8 and Figure 9 
respectively. The majority of colonoscopists were above the national standard 
and within the 95% confidence limits. Ninety nine (76.7%) of colonoscopists 
were above the national standard. Twenty three (17.8%) colonoscopists were 
outliers of whom 16 (12.4%) were above the upper limit and 7 (5.4%) below 
the lower limit. Twenty three (17.8%) were below the national standard but 
above the lower limit. Using the global mean for ADR, the majority of 
colonoscopists were again within the confidence limits. Eighteen (14.0%) 
were outliers, 5 (3.9%) being above the upper limit and 13 (10.1%) below the 
lower limits. 
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Table 4: Summary of CIR per unit 
 
Unit Number of 
colonoscopists 
No. of procedures 
performed 
CIR (%) 
(95% CI) 
A 3 120 90.0 
(83.0-94.5) 
B 10 303 91.2 
(89.0-94.5) 
C 8 325 92.9 
(89.5-95.4) 
D 6 257 91.8 
(87.2-94.4) 
E 15 556 89.0 
(86.1-91.4) 
F 16 829 93.7 
(91.8-95.2) 
G 9 342 93.9 
(90.7-96.1) 
H 13 563 93.4 
(91.0-95.3) 
I 14 379 91.8 
(88.5-94.3) 
J 14 247 91.1 
(86.7-94.2) 
K 9 373 90.0 
(87.4-93.5) 
L 12 454 90.5 
(87.4-93.0) 
Total 129 4748 91.9 
(91.1-92.7) 
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Figure 4: Funnel plot showing each unit‟s CIR with respect to the national 
standard 
 
 
Figure 5: Funnel plot of each colonoscopist‟s CIR relative to the national 
standard 
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Table 5: Summary of ADRs per unit 
Unit Number of 
colonoscopists 
No. of procedures 
performed 
ADR (%) 
(95% CI) 
A 3 120 17.5 
(11.4-25.7) 
B 10 303 13.5 
(10.0-18.0) 
C 8 325 14.5 
(10.9-18.9) 
D 6 257 10.1 
(6.8-14.6) 
E 15 556 18.3 
(15.3-21.9) 
F 16 829 16.4 
(14.0-19.1) 
G 9 342 15.8 
(12.2-20.2) 
H 13 563 17.2 
(14.3-20.7) 
I 14 379 15.3 
(11.9-19.4) 
J 14 247 17.8 
(13.4-23.3) 
K 9 373 14.2 
(10.9-18.3) 
L 12 454 17.2 
(13.9-21.0) 
Total 129 4748 15.9 
(14.9-17.0) 
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Figure 6: Funnel plot showing unit ADR with respect to the national standard 
 
 
Figure 7: Funnel plot showing unit ADR with respect to the global mean 
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Figure 8: Funnel plot showing each colonoscopists ADR with respect to the 
national standard 
 
 
Figure 9: Funnel plot showing each colonoscopists ADR with respect to the 
global mean 
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Adverse Events 
All colonoscopy related adverse events during the baseline period were 
collected and summarised in Table 6. There was one death within 30 days of 
colonoscopy in which the procedure was abandoned in the rectum due to 
poor preparation. The patient later suffered a cardiac arrest and died due to 
acute left ventricular failure. It was felt that bowel preparation may have 
contributed to death. 
 
Table 6: Summary of adverse events during baseline period 
 Number Incidence (%, n=4,748) 
Bleeding   
Minor 4 0.08 
Intermediate 1 0.02 
Major 0 0 
Fatal 0  
Perforation   
Major 1 0.02 
Fatal 0 0 
Other unplanned event   
Minor 5 0.10 
Intermediate 0 0 
Major 0 0 
Fatal 1 0.02 
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2.4. Discussion 
It was important to understand the performance levels within the study region 
prior to any intervention. The analysis of the data from a three month period 
from the participating 12 units provided an appropriate representation of 
colonoscopy practice within the region. 
 
It can be difficult to compare performance of individual colonoscopists and 
endoscopy units, particularly as the number of procedures performed are 
likely to be variable. The use of funnel plots takes into account „common 
cause variation‟. This type of variation is greater when a sample size is small. 
Furthermore, representing data graphically allows a thorough, rapid and 
meaningful analysis to be performed. 
 
The funnel plot in which all the colonoscopists CIR is summarised shows that, 
whilst there was variation between endoscopy units, all were within the 95% 
confidence limits. For individual colonoscopists, all but one (0.8%) were above 
the lower limit of the funnel. Furthermore, the majority were grouped around 
the 90% national standard suggesting that this standard remains appropriate. 
The global mean of 92.5% (CI 91.2-92.6) highlights that CIR within the units 
studied is in line with national recommendations and significantly better than 
the BSG audit published in 2004. 
 
It is evident analysing the funnel plots summarising the ADR data created 
relative to the current national standard of 10%, that all units are within the 
funnel, with 10 units above the upper 95% limit. When each colonoscopist‟s 
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ADR is plotted, there is wide dispersion with the overwhelming majority lying 
above the current national standard and 12.4% above the upper confidence 
limit. This calls into serious question whether the national standard of 10%, 
set in 2006, is too low. Using the global mean of 15.9%, a more even 
distribution is seen at both a unit and colonoscopist level, as would be 
expected. This study data provides powerful evidence that the national 
standard for ADR should be reviewed and that 15%, at the very least, is a 
more appropriate standard. Both plots for ADR reveal the wider variation that 
exists for this quality marker. Using the global mean for ADR also results in 1 
unit falling below the lower 95% confidence limit and increases in the number 
of colonoscopists below the lower limit (10.1% vs. 5.4%). 
 
Complications were few with post-polypectomy bleeding and perforation rate 
similar to that reported in other published series. (40-42) The bowel 
preparation related death does highlight the importance of adequate patient 
assessment prior to prescribing. 
 
The benefit of using funnel plots to evaluate performance is avoidance of 
unnecessary investigation of those falling below expected standards simply 
due to „common cause variation‟ rather than true under performance. This tool 
has been shown to aid health service decision making. (43) Whilst not 
traditionally presented on funnel plots, it is important to consider that each 
data point has its own error (i.e. 95% CI) which may cross the limits of the plot 
and is more likely for individuals or units performing lower procedure numbers 
where the CI will be wider. Therefore, it is important to interpret plots with care 
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when individuals have performed a small number of procedures and 
reassessment may be required when larger numbers can be included. The 
funnel plots for CIR also draws attention to the procedure numbers that need 
to be performed to ensure that an individual colonoscopists CIR is truly above 
national standards considering the error for the sample size evaluated i.e. that 
the lower limit for the individual is above the lower limit for the plot. This is an 
issue that has been highlighted previously and has implications for 
demonstration of ongoing competence and performance, particularly for 
trainees. (44) 
 
Funnel plots are often used to evaluate performance data as a „snap-shot‟. 
Maintaining quality, however, is a continuous process and early identification 
of deteriorating performance prior to falling below lower confidence limits is 
preferable. Funnel plots using cumulative data or using change in 
performance at two time points may be useful methods of monitoring for this 
purpose. (45) 
 
In summary, funnel plots are a powerful tool with which to rapidly analyse 
performance data and highlight both good and poor performance. The CIR 
within the participating units comfortably meets current requirements but is 
not, on its own, a complete quality measure. Whilst ongoing monitoring is 
required to ensure standards are maintained, the results will not be presented 
in this thesis. Adverse events were also in keeping with other large published 
series confirming that safety within the region is acceptable. Analyses of 
ADRs in this period strongly indicate that the current standard of 10% is too 
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low. This is supported by another study from a single UK endoscopy unit that 
included 10,026 procedures reported a global ADR of 19.2%. (46) The 
baseline mean of 15.9% is a good marker of the standard of colonoscopy 
within the study region. Therefore, this was considered a more appropriate 
reference standard against which to measure changes in performance 
observed in this study. The variation in the ADR was also a significant finding 
which highlighted the need for further improvement across all units. 
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Chapter Three: Improving Adenoma Detection 
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Chapter Three: Improving Adenoma Detection 
3.1. Introduction: methods of improving adenoma detection 
The previous chapter highlights the six to ten fold variations that exist in ADR 
in the participating units within the northern region. Service improvement 
interventions aim to improve standards of care, although it is often not 
possible to improve standards amongst those performing well. Interventions 
are primarily aimed at individuals whose performance is below average, with 
the effect of reducing variation and improving the overall quality of the 
services delivered to patients. Certain measures used during colonoscopy 
withdrawal, in addition to good colonoscopy technique, have been shown to 
improve lesion detection. 
 
3.1.1. Colonoscopy withdrawal time 
The time spent viewing the colonic mucosa has been raised as a potential 
factor that could influence lesion detection. The relationship between an 
endoscopist‟s withdrawal time and polyp detection rate (PDR) was studied by 
Simmons et al. (47) Data were retrieved from the computerised database at 
the Mayo clinic in the United States (US). Colonoscopies performed for 
routine indications were selected for analysis. The mean withdrawal time 
(MWT) was calculated using normal colonoscopies only to more accurately 
reflect mucosal viewing time as opposed to time spent performing therapeutic 
procedures. A total of 10,955 colonoscopies performed by 43 colonoscopists 
were studied. A longer MWT was associated with a higher PDR. The median 
PDR correlated with a withdrawal time of 6.7 minutes. The results are 
summarised in Figure 10. 
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Figure 10: Relationship between mean withdrawal time and PDR (reproduced 
with permission from Alimentary, Pharmacology and Therapeutics) (47) 
 
 
These data were supported by a prospective study performed by Barclay et al 
assessing the correlation between adenoma detection and colonoscopy 
withdrawal time in screening colonoscopies. (30) The MWT was again 
calculated using normal colonoscopies only. Adenoma detection was given 
both as ADR and mean number of adenomas per subject screened. In 
addition, the association with advanced adenomas (defined as adenomas 
>10mm, villous histology, high grade dysplasia or cancer) detection was 
studied. Two thousand and fifty three colonoscopies were performed by 12 
colonoscopists. A longer MWT was again associated with higher adenoma 
detection. Furthermore, colonoscopists with a MWT greater than 6 minutes 
had significantly higher adenoma detection for all adenoma and advanced 
adenomas as shown in Table 7.  
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Table 7: The association between MWT and adenoma detection (reproduced 
with permission from the New England Journal of Medicine) (30) 
 
 
These studies support the use a withdrawal time of at least 6 minutes that, in 
addition, is recommended by several guidelines. (18, 23)  Despite this many 
colonoscopists take less than 6 minutes to withdraw the scope. It must also be 
emphasised that colonic mucosa must be carefully inspected during this time 
with careful examination of folds and flexures and adequate suctioning and 
aspiration of fluid pools. (31) 
 
3.1.2. Antispasmodic use during colonoscopy withdrawal 
Factors that can hinder mucosal inspection are the presence of folds and 
colonic spasm. Whilst the tip of the colonoscope can and should be used to 
depress and view behind folds, it can be difficult. The use of antispasmodic 
agents can relax colonic smooth muscle thereby reducing spasm and the 
prominence of folds. The most commonly used agent is hyosine N-
butylbromide (Buscopan) although glucagon and peppermint oil (given 
topically via the colonoscope) are used. Bowles et al reported that 
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antispasmodics were used in approximately 20% of the colonoscopies studied 
in their audit. (10) 
 
A prospective randomised placebo controlled trial of the effect of Buscopan on 
polyp detection was performed by Lee et al. (48) The principal outcome 
measures for the study were change in colonic spasm score and number of 
polyps detected. A statistically significant reduction in spasm score was seen 
in the Buscopan group. More polyps were detected in patients with moderate 
to severe spasm receiving Buscopan compared to placebo, however, this 
didn‟t quite reach statistical significance (p=0.06). 
 
Regarding evidence to support antispasmodic use to improve the visualised 
colonic surface available for inspection, one study examined the effect of 
Buscopan on colonic surface area visualised at computed tomography (CT) 
colonography. CT colonography is a radiological test used for colonic 
assessment when colonoscopy is felt to be unsafe or is refused by the patient. 
Images are taken both in the supine and prone position in order to shift 
luminal fluids and contents and maximise mucosal views. The computer 
software also calculates the colonic surface visualised. This study revealed 
that significantly more colonic surface was visualised in both the supine and 
prone positions with Buscopan use compared with when no antispasmodics 
were used. (49) 
 
In addition to the above studies, expert colonoscopists recommend the use of 
Buscopan, particularly for lesions that may be difficult to detect or resect. (50) 
 63 
 
Together there is sufficient evidence, albeit at lower levels, to suggest that the 
routine use of Buscopan for the withdrawal phase of colonoscopy may 
improve mucosal visualisation and adenoma detection.  
 
3.1.3. Dynamic position change during colonoscopy withdrawal 
Colonoscopy has traditionally been performed with the patient lying on their 
left side (left lateral position) with the knees drawn up so that the thighs are at 
approximately 90 degrees to the torso. The anatomy of the colon dictates that 
this is often not the ideal position for passage of the colonoscope along its 
entirety as certain segments have a tendency to be collapsed making 
insertion and mucosal inspection difficult. The concept of changing the 
position of the patient has been used for some time in radiological 
assessments of the colon, initially barium enema studies and more recently 
CT colonography. (51) The objective of position change is to allow luminal gas 
to rise and fluid to drain away from the colonic segment of interest. The 
positions that allow optimal luminal distension and mucosal visualisation for a 
given colonic segment were taken from the experience of these radiological 
tests and have been used with increasing frequency in recent years to aid 
colonoscope insertion and withdrawal. 
 
The potential benefits of dynamic position change on luminal distension and 
adenoma detection were studied by East et al who performed a randomised, 
crossover trial comparing examination of the colon in the left lateral position 
and with dynamic position changes. (52) Consecutive patients presenting for 
routine colonoscopy were invited to participate in the study. Patients with 
 64 
 
known colitis, polyposis syndromes or musculoskeletal problems precluding 
position changes were excluded. Following caecal intubation, the 
colonoscope was withdrawn to the rectum with the patients either in the left 
lateral position or with dynamic position change (as shown in Figure 11) as 
dictated by the randomisation process. The colonoscope was subsequently 
re-inserted to the caecum and withdrawn using the alternative technique to 
the original. Polyps were only removed after the second withdrawal. The 
number of adenomas per segment and degree of luminal distension were 
recorded. The study demonstrated an increase in the number of adenomas 
detected in the segments where the optimal position for examination differs 
from the left lateral position. This was statistically significant for examination of 
the transverse colon (p=0.02). Luminal distension was also significantly better 
with the use of position change and this was positively correlated with the 
increase in adenoma detection. 
 
The most significant limitation of the study was that it was a single operator 
study. It does, however, support the proof of concept that adenoma detection 
can be increased with position change, in particular the use of the supine 
position for examination of the transverse colon which can be achieved simply 
during colonoscopy withdrawal. 
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Figure 11: Optimal patient position to examine each colonic segment 
(reproduced with permissions from Gastrointestinal Endoscopy) (52) 
 
 
 
3.1.4. Retroflexion within the rectum 
Detection of lesions low in the rectum can sometimes be difficult with the 
colonoscope in the forward viewing position. Better views of the distal rectum 
can be achieved by retroflexing the colonoscope in the rectum. This also 
provides a better position to sample or remove lesions. Whilst retroflexion 
within the rectum is a simple and safe technique, it is not performed routinely 
by all colonoscopists. 
 
One study looked polyp detection among patients in whom examination of the 
distal rectum was performed initially in the forward viewing position and 
subsequently in the retroflexed position. (53) In this study, 12 polyps (2.5% of 
all) were seen only in the retroflexed position, of which 4 were adenomas. 
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There were no adverse events associated with retroflexion. The simplicity and 
safety of retroflexion and the potential to increase adenoma detection suggest 
that its routine incorporation into withdrawal technique would be of use. 
 
The Quality in Colonoscopy (QIC) Study 
An opportunity arose for me to participate in a study evaluating the process of 
implementing evidence into routine colonoscopy practice in a large scale 
service improvement initiative. This involved evaluating both the feasibility and 
clinical effect of integrating an evidence-based „bundle‟ of measures into 
routine colonoscopy practice. The measures described above shown to 
improve adenoma detection are simple, safe and feasible to perform routinely 
in clinical practice and, if used in combination as a „bundle‟, could significantly 
improve ADR. Therefore, the QIC study „bundle‟ consisted of:   
 
1. A minimum withdrawal time from the caecum to anus of 6 minutes in all 
individuals with an intact colon. 
2. Antispasmodic use for withdrawal where no contra-indication exists. 
3. Examination of the transverse colon with the patient in the supine 
position. 
4. Examination of the distal rectum in the retroflexed position (in addition 
to the forward viewing position) where no contra-indication exists. 
 
The measures above are used by some colonoscopists but not by all and not 
routinely. The hypothesis being tested in this thesis is that incorporation of the 
„bundle‟ into routine colonoscopy practice, in combination with good 
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colonoscopy technique during withdrawal, is feasible and could improve 
mucosal visualisation and consequently improve the ADR. 
 
3.2. Changing Behaviour in Healthcare Professionals: the challenges of 
introducing evidence into clinical practice 
The use of a standardised or protocol based care approach within the NHS 
has long been thought of as a useful method of delivering a high quality 
service that provides the most up to date evidence-based care. (54)  The 
incorporation of this approach into clinical practice involves changing 
behaviour and attitudes in healthcare professionals, a process which can be 
challenging. (55, 56) Resistance can be encountered to even simple changes, 
such as completion of forms to document time of intravenous catheter 
insertion, and changes may not be uniform or consistent. Various studies 
have investigated how well evidence-based practice (EBP) and national 
guidelines are adhered to across the world and have been shown to be 
variable.  (57) In the US and Holland, it has shown that between 30% and 
40% of patients receive clinical care that is not in keeping with the latest 
scientific evidence. (58) 
 
Achieving changes in behaviour has become increasingly important in recent 
years due to the importance of EBP and the increasing number of clinical 
guidelines. Much work has been performed studying how we can improve 
engagement with current evidence and guidelines. (57, 59-61) This type of 
work is known as implementation research. 
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3.2.1. Awareness of and identifying barriers to change 
There are many potential factors that may influence willingness to change 
clinical practice and it is vital to be aware of these barriers and understand 
how they can be identified prior to developing a method of implementation.  
 
The National Institute for Health and Clinical Excellence (NICE) provide 
literature on how to understand, identify and overcome barriers to change and 
highlight several important areas. (56) Knowledge of the most up to date 
evidence or guidance is one potential barrier. It is difficult to remain aware of 
the increasing number of guidelines and scientific papers that are produced 
and also how they are best integrated into current practice. The acceptance of 
guidelines or evidence is also a potential barrier if they conflict with a 
practitioner‟s own views on a topic or alternative guidance. Motivation is also 
crucial to bringing about change. This may be provided by external factors, 
such as rewards or penalties for non-engagement. Internal factors, such as an 
individual‟s drive to improve, are also very important. The presence of the 
appropriate skill set to bring about change must also be considered and 
training may be required before the implementation process can begin. The 
practicalities of implementing a standardised care approach are, of course, an 
important consideration including a lack of resource or personnel, or the lack 
of infrastructure within an organisation to allow a particular change. Finally, 
there may be barriers, such as financial or political factors, that are beyond 
the immediate control of a particular organisation that may limit the 
implementation of guidelines. 
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There are many ways that the possible barriers to change can be identified, 
each of which has advantages and disadvantages. The chosen method 
should be selected in accordance with the information required and feasibility 
in a given setting. Use of questionnaires is one method of identifying barriers. 
This has the advantage of allowing relatively large amounts of information to 
be collected quickly and at low cost. Limitations include poor response rates 
and self-reporting bias which can affect the quality and type of information 
collected. Running a focus group of individuals involved in the respective care 
team can be useful, however, this can be difficult both to organise and 
analyse. Other useful methods are the use of brainstorming sessions, 
observation of clinical practice and talking to key individuals in the 
organisation to assess the feasibility of the proposed intervention. Once the 
potential barriers to change have been identified, it is important to develop a 
structured approach to implement the required changes.  
 
3.2.2. How should we implement a standardised care approach? 
When deciding how best to implement changes in practice, it is vital to 
consider all the barriers discussed in the previous section in order to achieve 
the best outcome. One method was proposed by Pawson and Tilley. (62) 
They suggest the following equation: 
 
Context (C) + Mechanism (M) = Outcome (O) 
 
In addition to helping us focus on the factors to be considered, this also 
highlights the potential problems that can be faced when attempting to bring 
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about change in large organisations. The often complex nature of these 
organisations can result in a different „context‟ depending on the member of 
the team being addressed. As a result, a single „mechanism‟ may not be 
adequate. The practicalities of developing several mechanisms of 
implementation across one organisation or system often dictates that 
comprises are required. When considering an endoscopy unit, potential 
barriers posed by colonoscopists are likely to differ from those posed by 
endoscopy nurses. Therefore, it is important to consider both and, where 
feasible, develop a model or mechanism that addresses the majority of 
potential issues. 
 
Rycroft-Malone et al studied in detail how standardised care approaches, 
such as the use of protocols and guidelines, worked in a variety of clinical 
settings. (63) They set out to answer the questions „what works, for whom, 
why and in what circumstances?‟ Importantly, they also studied how different 
„mechanisms‟ were developed and how this influenced their acceptance. This 
detailed study yielded many interesting results. When developing the 
„mechanism‟ of delivery, the authors made the following propositions: 
 
A clear understanding about the purpose and nature of protocol-based care 
by potential users will determine the extent to which standard care 
approaches are routinely used in practice. 
 
1. Standardised care approaches that are developed through a systematic, 
inclusive, and transparent process may be more readily used in practice. 
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2. Standardised care approaches that are based on a clear and robust 
evidence base are more likely to impact positively on outcomes. 
3. Locally developed standardised care approaches may be more acceptable 
to practitioners and consequently more likely to be used in practice. 
4. More senior and experienced clinical staff will be less positive than junior 
and/or inexperienced staff about using standardised care approaches. 
5. Interactive and participatory approaches and strategies to implement 
standardised approaches to care may influence whether or not they are 
used in practice. 
6. The support of a project lead may increase the likelihood of the ongoing 
use of standardised care approaches. 
7. Some contexts will be more conducive to using standardised care 
approaches than others, but it is unclear what might work in what 
circumstances and how. 
 
The study also reported many useful results regarding the reasons that some 
„mechanisms‟ were more effective than others. Factors that were positively 
associated with uptake included: 
 
1. Location and visibility: protocols were more likely to be used if they were 
highly visible. 
2. Incentives: protocols linked to financial incentives were more closely 
adhered to. 
3. Buy-in and ownership: when the whole multi-disciplinary team has been 
actively involved in protocol development it was more likely to be used. 
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4. Making a difference: when a protocol was perceived as making a 
difference to their practice and patient care. 
5. Embedding into systems: when protocols were integrated into 
documentation or IT systems. 
6. Ongoing project lead: the presence of a clear leader encouraged use of 
protocols and allowed for ongoing monitoring. 
 
The development and implementation of standardised care mechanisms is a 
complex area that we are yet to understand completely. However, some of the 
principles discussed here can be utilised to aid the process.  
 
3.3. An Intervention to Decrease Catheter-Related Bloodstream 
Infections in the ICU: An example of successful implementation of an 
intervention „bundle‟ 
The concept of using an evidence-based intervention „bundle‟ in order to 
improve the quality and safety of clinical practice was tested by Pronovost et 
al. (64) The problem identified by this group was the high number of catheter 
related blood stream infections that were occurring in the intensive care unit 
(ICU) in the US, together with the resulting morbidity, mortality and cost 
issues. Previous small studies had demonstrated that good education 
regarding central line management could successfully reduce catheter related 
infections. Pronovost et al aimed to study the extent to which such infections 
could be reduced by implementing a similar intervention in a state-wide safety 
initiative regarding patients in ICU.    
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All hospitals within the state with an adult ICU were invited to participate in the 
study. Units that agreed were asked to nominate at least one physician and 
one nurse as team leaders. The team leaders were instructed in the science 
of safety and the interventions and then disseminated the information to 
colleagues in their respective units. The ongoing support consisted of 
fortnightly conference calls, coaching by research staff and state-wide 
meetings twice a year. Supporting information on each component of the 
intervention, suggestions for implementation and instructions regarding data 
collection were also provided. Team leaders were partnered with their local 
infection control practitioners to aid implementation and assist with data 
collection. The intervention consisted of the following measures that were to 
be performed during all central catheter insertion and subsequent 
management: 
 
 Hand washing. 
 Use of full barrier precautions during catheter insertion. 
 Use of chlorhexidine to disinfect the skin prior to catheter insertion. 
 Avoiding the femoral site (where possible). 
 Prompt removal of unnecessary catheters. 
 
Locally team leaders educated colleagues regarding practices to control 
infection and harm due to central catheter-related infections. A central-line 
cart with necessary equipment was created and a check-list provided. 
Providers were stopped (in non-emergency situations) if practices were not 
being adhered to. Finally, removal of catheters was discussed at daily ward 
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rounds. Teams also received feedback regarding the number and rates of 
catheter-related infections at monthly and quarterly meetings. All units were 
asked to provide data on the number of catheter-related infections (expressed 
as number of infections per 1000 catheter-days) for the three month period 
before implementation and used as a baseline measure for each unit. The 
change in rate of catheter-related infections after implementation of the 
„bundle‟ was recorded for the eighteen months following implementation.   
 
A total of 103 ICUs from 67 hospitals provided complete datasets and were 
therefore included for analysis. A significant reduction in bloodstream 
infections related to central catheters was demonstrated at both 3 months, 
indicating efficacy of the intervention, and at 18 months demonstrating its 
durability. Results are summarised in Table 8. 
 
Table 8: Summary of reduction in catheter-related bloodstream infections 
(reproduced with permission from the New England Journal of Medicine) (64) 
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In addition to this initial work, further data has been published by the group 
showing that the reductions in catheter-related bloodstream infections brought 
about by this intervention were sustained four years after implementation. (65) 
 
In line with existing evidence on methods of improving organisational and 
individual performance, Pronovost et al confirmed that the following strategies 
can be used to successfully implement evidence into practice: 
 
 A standardised care pathway based on good quality clinical evidence. 
 Identification of enthusiastic team leaders to initiate and support 
implementation. 
 Training on how to perform each component of the „bundle‟ provided to 
leaders. 
 Resource provision i.e. providing all equipment in a trolley including 
provision of a checklist. 
 Penalties for non-compliance i.e. individual stopped performing procedure 
 Embedding the „bundle‟ into unit infection control systems. 
 Regular feedback of results to units and individuals. 
 On-going central support. 
 
On current evidence, it would seem reasonable that an evidence-based 
intervention „bundle‟ could be successfully be integrated into routine clinical 
practice and yield long-lasting results when the appropriate mechanism for 
introducing change is used. The next chapter outlines how the evidence 
discussed on implementation of clinical evidence into practice and the 
 76 
 
measures shown to improve adenoma detection were combined to develop 
an implementation process and educational package for the current study. 
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Chapter Four: Did the intervention successfully change 
practice? 
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Chapter Four: Did the intervention successfully change practice? 
4.1. Introduction 
The factors discussed in chapter 3 were carefully considered when designing 
the intervention „bundle‟ and selecting the process of implementation in this 
study. In the setting of a busy endoscopy unit, it was felt that the most 
important factors regarding the „bundle‟ were that it should be:  
 based on good quality evidence 
 safe 
 simple (including no need for additional training) 
 time efficient 
 inexpensive  
 reproducible 
The measures in the study „bundle‟ certainly meet these criteria and can be 
performed without adversely affecting the number of procedures on any 
endoscopy list. Therefore, incorporating these measures into an evidence-
based intervention „bundle‟ for routine use during the withdrawal phase of 
colonoscopy should be feasible and could improve the standard of the 
colonoscopy without adversely affecting procedure volume or adding 
significant cost.  
 
Ethical Approval 
The QIC study was a service improvement initiative in which all participating 
units were to receive the intervention. The study was reviewed by the 
chairman of the Sunderland Research Ethics Committee (REC) who felt that, 
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as a service improvement project, formal ethical review was not required and 
issued a waiver stating this (Appendix B). 
 
4.2. Methods 
4.2.1. The Implementation Process 
As with development of the „bundle‟, the model of implementation must also 
take into account the setting into which it is to be introduced. The process of 
implementation utilised by Provonost et al included many features that would 
also be useful in an endoscopy setting. Therefore, this model was used as a 
base from which to design the implementation process used in this study. 
 
A de novo, multifaceted implementation model was developed that included a 
single central training session for leads and local training sessions at each 
site led by the study team. Information was provided detailing the evidence on 
which the „bundle‟ was based both in written form and by way of a DVD. A 
follow up visit a minimum of four months after implementation was planned at 
which preliminary results would be presented. The study leads were also 
charged with continuous local study promotion. The programme was 
consensus based and peer led (including peer participation) which are proven 
powerful education tools. (66-68) It utilised standard endoscopy teaching 
practices to ensure it would be familiar those working in this environment. The 
programme was reviewed and endorsed by the NREG committee. Roll out 
was incremental with the first units acting as a pilot to identify and solve any 
unidentified problems. 
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4.2.1.1. Central Training 
A central training day was organised at which all lead colonoscopists and lead 
endoscopy nurses from the participating units were required to attend. 
Members of the central study team led the session. The team consisted Dr 
Colin Rees (CR), Dr Brian Saunders (BS), Dr James East (JE), Dr Matt Rutter 
(MR) and Professor Mike Bramble (MB). Team members were selected as 
they were considered to be leaders in the field of colonoscopy and due to their 
expertise in colonoscopy training and in management within the NHS. All 
sessions were interactive. The outline for the training day is shown in Table 9. 
 
Table 9: Summary of central training day 
 
Section Title Summary of content Session 
lead 
Introduction  MR 
Overview of the 
Quality 
Improvement in 
Colonoscopy 
(QIC) Study 
Current variability in colonoscopy. 
Quality markers in colonoscopy 
Factors influencing ADR 
An example of a successfully 
implemented „bundle‟ 
The QIC „bundle‟ 
 
 
 
JE 
NREG and the QIC 
study 
Summary of NREG 
How NREG can help with the QIC study 
 
CR 
 
Academic 
detailing and 
educating doctors 
How to change behaviour 
Who can influence/encourage 
colonoscopists to change practice? 
Feedback and changing practice  
 
 
MB 
Live video-linked 
demonstration of 
the QIC „bundle‟ 
Demonstration of the QIC „bundle‟.  
BS 
Feedback Identification of local barriers 
Suggestions to aid local implementation 
 
CR 
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The minutes of the meeting, including a breakdown of the questions raised 
and answered and suggestions to aid implementation, is provided in Appendix 
C. The key suggestions and points of discussion were as follows: 
1. Local training sessions were to be led by myself (PTR), to aid consistency, 
supported by the local leads. Sessions must be a maximum of 45 minutes 
long so they can be efficiently delivered in a busy clinical setting. 
Discussion took place regarding whether a more senior member of the 
study team should lead local training sessions and also whether a surgeon 
should present to surgical colonoscopists, who might be more difficult to 
engage. However, it was felt that this would be logistically more difficult, in 
addition to adding variability to training. 
2. Assessment of compliance to be performed by endoscopy nurses to 
evaluate uptake of the „bundle‟. Endoscopists should be aware that 
assessments will be performed but blinded as to when the assessments 
were taking place. 
3. Engage all endoscopy nurses as they could potentially influence 
colonoscopists uptake of the „bundle‟. 
4. Posters to act as a reminder in all endoscopy rooms. 
5. Letter to all medical directors at participating units to inform them about the 
study and gain their support to encourage uptake. 
 
Following the central training day, the implementation model was modified to 
include separate sessions for the endoscopy nurses in order to engage and 
empower their involvement in the study. A study poster was also designed for 
all endoscopy units (Appendix D). 
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4.2.1.2. Local Training 
The session consisted of a 30-45 minute interactive training session 
(Appendix E) and a study information pack which contained both written 
information regarding the study (Appendix F) and a DVD demonstrating the 
components of the „bundle‟ (Appendix G) followed by time for questions. An 
A2 poster was provided for each of the endoscopy rooms in the participating 
units. 
 
The leads invited all colonoscopists in their respective units to take part in the 
study. Local training sessions, led by myself, were organised at times that 
would allow for maximal attendance. Multiple visits were required for some 
units if feasible and the initial attendance was particularly low. Registers were 
kept for all sessions. Colonoscopists who were not able to attend these 
sessions were provided with the study information pack and were contacted 
by the lead colonoscopist for the respective unit who gave a brief outline of 
the study and answered any questions. Colonoscopists were informed that 
endoscopy nurses would perform compliance assessments in order to monitor 
whether or not the „bundle‟ was being used, but that they would not to be 
made aware when the assessments were taking place.  
 
Colonoscopists were also asked to complete a short questionnaire regarding 
how frequently they used the measures comprising the „bundle‟ in their 
practice prior to the study (Appendix H). Lead colonoscopists distributed and 
collected the questionnaires for those who could not attend the training. 
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At the central training day, it was identified that the nursing staff working in 
each endoscopy unit could play a significant role in bringing about and 
maintaining change in practice among the participating colonoscopists. 
Therefore, we considered enlisting and encouraging the participation of the 
nurses as an important element of the implementation process. A separate 
session was arranged for the nurses that worked in each endoscopy unit 
organised by the lead endoscopy nurse. The session included a similar (albeit 
shorter) version of the talk given to the endoscopists, including an outline of 
the study and the components of the „bundle‟. The nurses were also informed 
that they would be asked to complete a brief compliance assessment form for 
a proportion of the colonoscopies performed by each colonoscopist. The 
assessment form (Appendix I) was presented and discussed and all questions 
answered. There were no immediate issues that arose as a result of the 
discussions regarding the assessment form. Furthermore, nurses were 
empowered and encouraged to promote the study including reminding all 
colonoscopists about the bundle and referring to the poster. 
 
4.2.1.3. Follow-up Sessions 
Following completion of local training at all participating units, there was 
regular contact with the lead colonoscopist and lead nurse at each unit. This 
consisted of a monthly e-mail, in which updates as to the progress of roll out 
were provided as well as reminders regarding the importance of the study 
promotion.  
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An update session was provided at all participating units between 4 and 6 
months of study commencement. During these sessions, preliminary results 
from all units were presented and discussed to act as a form of ongoing 
encouragement. An A4 size poster of these results was also provided to each 
unit and it was requested that this be placed alongside the study poster 
(Appendix J). Registers were kept at all update sessions. The lead 
colonoscopists were also provided with an e-mail consisting of a brief 
presentation and discussion of the preliminary results, which could be 
forwarded to all colonoscopists within the unit (Appendix K). 
 
4.2.2. Data Analysis 
It was important to understand whether our intervention was successful in 
bringing about a change in practice amongst the participating colonoscopists. 
Due to the logistics of delivering the educational package across all 
participating units, data from the first quarter of the year (1st January to 31st 
March 2011 inclusive) included a mix of data from both the pre and post-
intervention periods. Therefore, this data was excluded from the analysis. 
Valid comparisons were for procedures undertaken between 1st October to 
31st December 2010 and 1st April to 31st December 2011 in order to best 
evaluate whether the intervention to change practice had been successful. To 
be included in the analysis, colonoscopists must have performed procedures 
in both periods. The process used to collect and clean the data has been 
described in chapter two and was also used to collect the post intervention 
data. 
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To better understand how the bundle affected colonoscopists at different 
performance levels, quartiles were created after ranking colonoscopists 
according to their baseline ADR. To be included in these analyses, 
colonoscopists must have performed a minimum of 25 colonoscopies during 
the baseline period. 
 
Assessing compliance with the intervention bundle through observation 
proved more challenging than originally expected. Lack of robust data and 
relatively small number of compliance assessment forms meant that the most 
reliable marker of uptake was Buscopan use. Thus, the change in Buscopan 
use rate (BR), defined as the proportion of procedures in which Buscopan 
was used expressed as a percentage, was used as a surrogate marker of 
compliance with our educational package.  
 
Comparisons were made at the level of the colonoscopist, unit, globally 
(inclusive of data from all 12 units) and between quartiles. The unit, quartile 
and global level data included sufficiently large sample numbers that the 
normal distribution approximation is valid. For the data at the level of the 
colonoscopist where numbers are smaller, an exact test was used.  
 
Whilst the data analysed is paired at the level of the colonoscopist, there are 
many other variables for which it is not possible to appropriately correct. 
These include patient factors such as age, gender, co-morbidities, quality of 
bowel preparation and tolerance of the procedure, as well as organisational 
factors that may influence uptake of the „bundle‟ and adenoma detection. The 
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main limitation was the difficulty in collecting reliable data regarding several of 
these factors due to variable documentation. In addition, the number of 
procedures that each colonoscopist performed also varied. Taking these 
factors into consideration, the most appropriate statistical analyses were to 
calculate the ratio of two binomial proportions together with its 95% 
confidence interval. The presence of a significant change was evaluated using 
a corrected Chi Squared and Fishers Exact test respectively. 
 
4.3. Results 
4.3.1. Attendance at training and follow-up sessions 
The QIC study began with a central training day held at University Hospital 
North Tees. Lead colonoscopists from all 12 units attended the session. Five 
non-lead colonoscopists from four units also chose to attend. Seven 
endoscopy nurse leads were able to attend the central training session, 
although, one subsequently handed over the role as lead to another nurse in 
the unit. A summary of attendance is shown in Table 10. 
 
Following the central training day, a local training session was arranged at 
each of the participating units to implement the „bundle‟. The attendance at 
these sessions was variable with some units requiring multiple sessions 
(when logistically feasible) to capture as many colonoscopists as possible. 
The percentage attendance ranged from 38.5% to 83.3%. The dates, number 
of sessions and attendance figures are summarised in Table 11. The timing 
and the set-up of the session, either study specific or added to another 
meeting, is summarised in Table 12. 
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The attendances by grade of those included in the analyses were as follows: 
consultant gastroenterologist 58.5% (24/41), consultant surgeon 31.6% 
(12/38), nurse endoscopist 66.7% (10/15), trainee in gastroenterology 61.5% 
(8/13). There was one general practitioner whose data were included in the 
analysis who attended and also one geriatrician and one trainee in surgery, 
whose data were included but who did not attend a training session. 
 
In addition to the training sessions for colonoscopists, a separate session was 
held for the endoscopy nurses to discuss the study and encourage them to 
promote use of the „bundle‟. In one unit (unit H), the lead nurse felt the most 
pragmatic way to circulate the required information was to meet with her and 
another of the senior sisters who would subsequently disseminate the 
information. In all other units, as many endoscopy nurses as possible 
attended the sessions and subsequently circulated the information to the 
remainder. 
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Table 10: Summary of attendance to central training day 
Unit Lead Colonoscopist Lead Nurse Non-lead 
colonoscopist 
A Y Y N 
B Y Y Y 
C Y Y* N 
D Y N N 
E Y Y N 
F Y N Y 
G Y N Y 
H Y Y N 
I Y N N 
J Y Y N 
K Y Y N 
L Y N Y 
    *Did not continue as lead nurse for the unit 
 
Table 11: Summary of initial training session, date and attendance 
Unit Number of 
sessions 
Date(s) Total number of 
colonoscopists* 
Number of 
attendees* (%) 
A 1 4/2/11 2 1 (50.0) 
B 1 28/2/11 9 5 (55.6) 
C 1 4/2/11 6 2 (33.3) 
D 2 21/1/11 + 27/1/11 6 5 (83.3) 
E 1 7/1/11 15 7 (46.7) 
F 2 14/1/11 + 27/1/11 15 7 (46.7) 
G 2 18/2/11+ 25/3/11 9 4 (44.4) 
H 2 27/1/11 11 4 (36.4) 
I 1 13/1/11 14 7 (50.0) 
J 1 21/1/11 12 5 (41.7) 
K 1 10/1/11 7 5 (71.4) 
L 2 18/2/11 + 25/3/11 12 8 (66.7) 
*Numbers include only colonoscopists whose data were included in analysis. 
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Table 12: Summary of timing and set-up of training sessions 
Unit Timing of session Session set-up 
A Afternoon Study specific 
B After hours Study specific 
C Afternoon Study specific 
D Afternoon Study specific 
E Afternoon Study specific 
F Afternoon Study specific + Before lower GI MDT 
G Afternoon Endoscopy users meeting + 
Endoscopy training session 
H Morning Study specific 
I Afternoon Before joint gastro-surgery meeting 
J Afternoon Prior to general surgery meeting 
K Afternoon After lower GI MDT 
L Afternoon Study specific + Endoscopy training 
session 
 
Following the initial training sessions, I (PTR) attended each unit for a follow 
up visit at between four and six months during which the preliminary results 
were presented to encourage engagement with the bundle. 
 
4.3.2. Self-reported use of the „bundle‟ measures prior to intervention 
During the training sessions, colonoscopists were asked to complete a short 
questionnaire regarding their use of the measures comprising our bundle in 
their routine practice prior to the study. A total of 80 questionnaires were 
returned, of which 59 (50%) were from colonoscopists that were included in 
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our post intervention analyses (see below). The results are summarised in 
Table 13. 
 
Table 13: Summary of how often each measure was used routinely 
 Always/nearly 
always (%) 
Often (%) Rarely (%) Never (%) 
Withdrawal 
time* 
26 (44.1) 23 (39.0) 9 (15.3) 1 (1.7) 
Buscopan 
use * 
7 (11.9) 14 (23.7) 23 (39.0) 15 (25.4) 
Position 
Change* 
19 (32.2) 23 (39.0) 13 (22.0) 13 (6.8) 
Retroflexion* 38 (64.4) 16 (27.1) 5 (8.5) 0 (0.0) 
*Numbers from colonoscopists whose data were included in analysis only. 
 
4.3.3. Change in Practice: compliance assessment forms and Buscopan use 
To be included in the comparative analyses, colonoscopists must have 
performed procedures in both periods. After applying this criterion, 118 
colonoscopists remained of whom there were 41 consultant 
gastroenterologists (34.7%), 39 consultant surgeons (33.1%), 15 nurse 
endoscopists (12.7%), 13 gastroenterology trainees (11.0%), 5 non-consultant 
grade staff (4.2%), and 1general practitioner, (0.8%), 1consultant geriatrician 
(0.8%), and 3 surgical trainees (2.5%).  
 
The 118 colonoscopists listed above performed a total of 4,351 colonoscopies 
during the baseline period included in the statistical analysis. The number of 
procedures performed per colonoscopist ranged from 1 to 143. A total of 
13,157 colonoscopies were performed during the period following the 
intervention excluding performance data from the first quarter (implementation 
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period). The number of procedures performed per colonoscopist ranged from 
1 to 464. Graphs summarising the spread of the number of colonoscopies 
performed is shown in Figure 12 and Figure 13 respectively.  
 
Figure 12: Summary of the number of procedures performed per 
colonoscopist during period before implementation of the „bundle‟ 
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Figure 13: Summary of the number of procedures performed per 
colonoscopist during period after implementation of the „bundle‟ 
 
 
Compliance Assessments 
The compliance assessments were completed to a variable standard. Forms 
were completed for 103 (87.3%) colonoscopists. There were a total of 2,040 
usable forms (15.5% of all procedures). The number of forms completed per 
colonoscopist is summarised in Figure 14. The interquartile range of the 
number of forms completed per colonoscopist was 5 to 23. The number 
completed per unit is summarised in Table 14. A summary of the results is 
provided in Table 15. Reasons that forms were not usable included no 
identification as to the colonoscopist being audited, presence of polyps, 
completed for a flexible sigmoidoscopy as opposed to full colonoscopy and 
being performed in patients with extensive bowel resections making the 
intervention measures irrelevant. 
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Figure 14: Number of forms as a proportion of the total number of 
colonoscopies performed per colonoscopist 
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Table 14: Summary of the number of forms completed per unit 
Unit Number of forms (% of 
total number of forms) 
Number of forms as a proportion of 
total number of procedures performed 
(%) 
A 69 (3.4) 26.1 
B 172 (8.4) 23.1 
C 154 (7.5) 32.3 
D 179 (8.8) 24.6 
E 270 (13.2) 13.0 
F 241 (11.8) 11.1 
G 6 (0.3) 0.6 
H 131 (6.4) 9.3 
I 221 (10.8) 21.7 
J 207 (10.1) 33.8 
K 301 (14.8) 25.7 
L 89 (4.4) 6.0 
 
 
Table 15: Summary of results of compliance assessment results 
 Yes (%) No (%) Field not 
completed 
(%) 
Unusable 
(%) 
CI (%) 
WT 1,718 (84.2) 170 (8.3) 93 (4.6) 52 (2.5) N/A 
Buscopan 1,645 (79.2) 391 (19.2) 7 (0.3) 0 (0.0) 188 (9.2) 
Position 1,822 (89.3) 235 (11.5) 12 (0.6) 0 (0.0) N/A 
Retroflexion 1,789 (87.7) 210 (10.3) 40 (2.0) 0 (0.0) 92 (4.5) 
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Buscopan use rate (BR) 
During the baseline period, Buscopan was used in 689 procedures globally 
translating to a BR of 15.8% (95% CI 14.8-17.0). In the period after the 
intervention, Buscopan was used in of 7,161 procedures globally, translating 
to a BR of 54.4% (95% CI 53.5-55.3). This was a statistically significant 
increase in BR (p<0.001).  
 
All units demonstrated a significant increase in the use of Buscopan. Table 16 
summarises the change in BR for all units, the ratio of proportions and the p 
value for the significance level of change during the pre and post intervention 
periods. Table 17 summarises the number of colonoscopists per unit that 
demonstrated a significant increase in BR. 
 
A total of 72 (61.0%) colonoscopists demonstrated a significant increase in 
their BR comprising 26 (36.6%) consultant gastroenterologists, 15 (21.1%) 
consultant surgeons, 1 (1.4%) general practitioner, 1 (1.4%) geriatrician, 4 
(5.6%) non-consultant grade staff, 13 (18.3%) nurse endoscopists and 11 
(15.5%) trainees in gastroenterology. A total of 43 (60.6%) had attended a 
local training session. The range of BR per colonoscopist during both the 
period before and after the intervention was 0 to 100%, the spread of which is 
shown in Figure 15 and Figure 16 respectively.  
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Table 16: Summary of change in BR in each unit together with the results of 
statistical analysis 
Before After 
Unit N Patients in 
whom 
Buscopan 
used 
BR (%) N Patients in 
whom 
Buscopan 
used 
BR (%) Ratio p 
value 
A 72 59 81.9 264 244 92.4 1.13 0.008 
B 275 7 2.5 745 289 38.8 15.24 <0.001 
C 191 9 4.7 477 321 67.3 14.28 <0.001 
D 247 32 13.0 729 339 46.5 3.59 <0.001 
E 556 141 25.4 2073 1382 66.7 2.63 <0.001 
F 791 106 13.9 2153 1283 59.6 4.45 <0.001 
G 344 70 20.4 959 408 42.5 2.08 <0.001 
H 465 112 24.1 1409 714 50.7 2.10 <0.001 
I 379 74 19.5 1018 731 71.8 3.68 <0.001 
J 235 30 12.2 612 365 59.6 4.67 <0.001 
K 341 4 1.2 1173 372 31.7 27.04 <0.001 
L 455 45 9.9 1545 713 46.1 4.89 <0.001 
N = number of colonoscopies 
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Table 17: Summary of the number of colonoscopists who demonstrated a 
significant increase in BR per unit 
Unit Number of colonoscopists with a 
significant increase in BR (proportion 
of colonoscopists as a %) 
A 1 (50.0) 
B 8 (80.0) 
C 5 (83.3) 
D 4 (66.7) 
E 7 (46.7) 
F 9 (60.0) 
G 4 (44.4) 
H 7 (63.6) 
I 9 (64.3) 
J 5 (41.7) 
K 3 (42.9) 
L 8 (66.7) 
 
Figure 15: Summary of BR per colonoscopist during baseline period 
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Figure 16: Summary of BR per colonoscopist during the period following 
implementation 
 
 
A total of 68 colonoscopists were included in quartile level analyses 
performing a total of 3,622 and 10,571 procedures during the „before‟ and 
„after‟ periods respectively. A significant increase in BR was demonstrated in 
all quartiles as summarised in Table 18. 
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Table 18: Summary of changes in BR in each quartile together with the 
results of statistical analyses. 
Before After 
Quartile No. of 
procedures 
Patients in 
whom 
Buscopan 
used 
BR 
(%) 
No. of 
procedure
s 
Patients in 
whom 
Buscopan 
used 
BR 
(%) 
Ratio p 
value 
Upper 785 183 23.3 2508 1832 73.0 3.13 <0.001 
Upper 
Middle 
1116 214 19.2 3119 1976 63.4 3.30 <0.001 
Lower 
Middle 
785 71 9.0 2539 892 35.1 3.90 <0.001 
Lower 936 74 7.9 2405 1094 45.5 5.76 <0.001 
 
4.4. Discussion 
The overall aim of this multi-faceted intervention was to introduce a „bundle‟ 
into routine colonoscopy practice to improve ADR by improving mucosal 
visualisation. The two key questions addressed by this thesis are: 
 
1. Can a “bundle” such as the one proposed be successfully implemented 
across a whole geographical region and can this be evidenced? 
 
2. If change can be achieved, will this improve ADR in those who appear to 
underperform and will it also reduce variance in ADR? 
 
In this chapter, the answer to the first of the two questions is presented and 
discussed. 
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The endoscopy nurses were asked to complete a simple compliance 
assessment form for a proportion of procedures performed by each 
colonoscopist in their unit. Forms completed for 87.3% of participating 
colonoscopists, however this represented only 15.5% of the total number 
colonoscopies performed. Among the compliance assessments completed, 
there was a very good uptake of all components of the „bundle‟. However, due 
to the limited proportion of procedures for which the forms were completed, 
the true level of uptake is unlikely to be as high as suggested by these data. 
 
All medications given during colonoscopy are documented on the endoscopy 
report and can subsequently be reviewed. As a result of the limited number of 
compliance assessments completed, the most robust method of evaluating 
whether there had been engagement with the „bundle‟ was to use change in 
the BR as a surrogate marker. There were no other initiatives during the study 
period that would have influenced BR and so it is reasonable to conclude that 
the change was as a result of the study intervention. This method does not 
allow evaluation of adherence to the remaining measures in the „bundle‟ 
which would, in any case, be harder to evidence. 
 
A significant increase in BR was observed globally and in all units. Regarding 
individual colonoscopists, 61.0% significantly increased their BR of whom 
39.4% had not attended the initial training session. The proportion of 
colonoscopists per unit in whom a significant increase in BR was seen ranged 
from 41.7% to 83.3% suggesting that change was not clustered. A significant 
increase in BR was also seen in all quartiles.  
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These results suggest a good level of engagement and adoption of the 
„bundle‟ among the participating colonoscopists with change observed in all 
units, rather than being focused amongst a few enthusiastic departments. 
Furthermore, change was also observed in those colonoscopists who did not 
attend a local training session. This provides evidence that the selected 
implementation model led to successful dissemination of the bundle out with 
the direct involvement of the study team.  
 
In order to evaluate the effectiveness of our model of implementation, we 
must have an understanding of expected change in behaviour for this type of 
intervention and consider factors that may have influenced uptake. In this 
setting, time constraints and cost efficiency were the most important factors, 
as discussed previously. 
 
Academic detailing has been used to improve patient care in a variety of 
clinical settings including improving colonoscopy practice, prescribing 
behaviour, adherence to guidelines in the management of chronic conditions 
and prevention of falls in care home residents. (69-71) The models used 
naturally differ in accordance with the aim of the project and the clinical 
setting. 
 
In a recently published study by Coe et al, the effect of an endoscopic quality 
improvement programme on detection of colorectal adenomas was studied. 
(72) Colonoscopists were randomised to either receive the educational 
intervention or continue their routine practice. All received feedback regarding 
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their baseline ADR and withdrawal times and were aware they were part of a 
study of ADR. However, those in the control arm were not aware that the 
other group had undergone an educational intervention. Training consisted of 
two separate one hour long sessions, which included the importance of good 
mucosal viewing technique in combination with longer withdrawal times to 
improve ADR. Training also included the use of optical enhancement tools 
such as narrow band imaging (NBI) the primary use of which is to characterise 
polyps. It was demonstrated that colonoscopists in the intervention arm 
significantly improved their ADR. Limitations of this work were that it was 
performed in a single academic centre study including only 15 colonoscopists. 
The two colonoscopists with the lowest ADR, and therefore biggest room for 
improvement, were also randomised, by chance, to the training group. 
Another potential issue is the length of the training sessions required to 
achieve change, which could potentially limit effective wider rollout particularly 
in a busy NHS setting. This issue will be discussed further later in this thesis.  
 
Larger scale interventions have been performed in other care settings. 
Grimshaw et al performed a systematic review to evaluate the effectiveness of 
guideline dissemination and implementation. (73) The study designs included 
in the analyses were cluster and individual randomised controlled trials 
(RCTs), controlled clinical trials, controlled before and after (CBA) studies and 
interrupted time series (ITS) that evaluated any guideline dissemination or 
implementation strategy targeting physicians and that reported an objective 
measure of provider behaviour and/or patient outcome. Interventions were 
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classified in accordance with the Cochrane-Effective Practice and 
Organisation of Care (EPOC) taxonomy as shown in Table 19. 
 
Table 19: Cochrane-Effective Practice and Organisation of Care (EPOC) 
taxonomy classification system (reproduced with the permission of Cochrane 
Database of Systematic Reviews) 
 
 
Of particular relevance to the QIC study are the results from studies utilising 
multifaceted interventions incorporating educational outreach. Of the 11 
controlled RCTs reporting dichotomous process measures, the median effect 
of the interventions was +6.0% (range -4% to +17.4%) absolute improvement 
in performance. The change reached statistical significance in five studies in 
which the median effect size was +10.0% (range -4.0% to +17.4%). Only the 
one study with a +17.4% study was statistically significant. Of the four CBA 
studies reporting dichotomous process measures, the median effect was 
+7.3% (range 5.6 to 16.4%) absolute improvements in performance. Of those 
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reporting continuous process measures, among the cluster RCTs analysed 
the median effect was +15% (range +1.7% to 24%) and for the single CBA, an 
11.3% relative improvement in performance.  
 
A sub-group analysis was also performed to evaluate the effect of educational 
materials and educational outreach compared to educational materials, 
educational meetings and educational outreach. It was concluded that the 
latter is likely to have the bigger effect, however, this is still likely to be only 
modest to moderate.  
 
The group also evaluated the effect of multiple interventions.  There was no 
clear relationship between the number of interventions i.e. training sessions, 
and the effect size overall, however, multiple interventions may have a modest 
additional effect on influencing prescribing behaviour. 
 
The Cochrane group has also performed a review of the effect of educational 
outreach visits (EOV) on professional practice and healthcare outcomes. (61) 
They included RCTs of EOVs that reported an objective measure of 
professional performance or healthcare outcomes. For dichotomous 
outcomes, results were given as an adjusted risk difference (RD) defined as 
the difference between intervention and control group means in compliance 
after the intervention minus the difference between the groups before the 
intervention, with a positive RD meaning compliance improved more in the 
EOV group. For continuous outcome measures, the post-intervention raw and 
adjusted mean differences were calculated. When possible the relative 
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percentage change was also calculated (adjusted difference between the 
post-intervention experimental and control group means divided by the post-
intervention control group mean x 100). 
 
There were a number of comparisons performed. One looked at any 
intervention in which EOVs were a component of the intervention compared to 
no intervention. Those with dichotomous health professional outcomes 
reported a median improvement of 5.6% (interquartile range 3.0% to 9.0%). 
Those reporting continuous healthcare professional outcome reported an 
adjusted relative percentage change varying from 0% to 617%. The median 
percentage change was 21% (interquartile range 11% to 41%). When studies 
in which EOV alone was the intervention compared with no intervention, those 
with dichotomous health professional outcomes demonstrated a median 
adjusted RD of 5.0% (interquartile range 3.0% to 6.2%) and those with 
continuous health professional outcomes a median percentage change of 
23% (interquartile range 12% to 39%).  
 
The intervention in the QIC study resulted in a significant and relatively global 
change in health professional behaviour as evidenced by a change in BR. The 
primary challenge of comparing outcomes of service improvement studies is 
the heterogeneity that exists within the evidence base due to methodological 
differences and the varied clinical settings. We must also consider that, whilst 
our intervention „bundle‟ encourages evidenced-based practice, with the 
exception of withdrawal time, the measures are not national guidance. 
Therefore, colonoscopists would not have been expected to perform the 
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measures as routine prior to the intervention and instead, would have done so 
variably as we demonstrate. This may potentially result in a larger change 
than in settings where guidelines already exist. Despite these considerations, 
the increase in BR is likely to demonstrate at least a moderate change in 
behaviour when compared to other educational interventions, suggesting our 
model of implementation was effective.  
 
Engagement with the „bundle‟ was primarily measured using BR as a 
surrogate marker as it was the most reliably documented. Use of a surrogate 
marker has inherent limitations which we accept. One such limitation is that 
Buscopan is potentially the simplest component of the „bundle‟ to comply with 
and is driven primarily by endoscopy nursing staff who both prepare and 
provide the drug. Therefore, it is possible that BR may be higher than 
compliance with the other measures within the „bundle‟. However, there is 
evidence from our qualitative work (presented in chapter 6) that suggests 
nurses also encouraged the use to rectal retroflexion and that the study 
training sessions did help some colonoscopists consider withdrawal time more 
carefully than prior to the intervention suggesting the overall implementation 
package had the desired effect of increasing awareness of quality measures 
and promoting uptake. 
 
One final consideration is that this study was conducted within an established 
collaborative research network and lead colonoscopists had volunteered to 
participate in the study. As a result, we accept that uptake may potentially be 
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higher than seen if rolled out to the rest of the UK where collaborative working 
may not be as well established. 
  
In summary, taken together and considering the limitations, both the change 
in BR and compliance assessment data demonstrate that the multi-faceted 
study intervention resulted in successful incorporation of evidence into routine 
clinical practice. When compared with data from other clinical settings, it is 
reasonable to describe the degree of change as at least moderate. The 
observations also suggest that dissemination of information occurred out with 
the direct involvement of the study team suggesting that good local promotion 
took place, supporting the selected model of implementation.  
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Chapter Five: What was the effect on adenoma detection 
rate? 
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Chapter Five: What was the effect on adenoma detection rate? 
5.1. Introduction 
The hypothesis that a “bundle” of evidence based changes in colonoscopy 
practice could be achieved through the implementation of an educational 
package as presented in the previous chapter proved correct indicating that 
the model of implementation was appropriate and successful in achieving 
significant changes in practice at all levels (individual colonoscopist, unit, 
globally and in all quartiles).  The hypothesis also included the tenet that 
effecting this change would improve mucosal visualisation and as a direct 
consequence improve ADR and reduce the variation that currently exists.  
 
5.2. Methods 
5.2.1. Data Analysis 
The processes of data collection, cleaning and comparative analyses were as 
described previously. Changes in ADR were also analysed using funnel plots 
that were created as described in chapter two, relative to the reference 
standard of 15.9% (the baseline mean before application of the 
inclusion/exclusion criteria) rather than the lower BSG standard of 10%. 
 
Calculating an appropriate sample size in the context of a service 
improvement project is challenging due to the heterogeneity in baseline 
performance and variable uptake of any intervention as discussed in the 
previous chapters. Regarding ADR, if we were to use the number of 
colonoscopies required to reliably demonstrate an absolute increase in ADR 
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of 5% and a relative increase of 25%, a sample size of 1504 colonoscopies 
would be required per analysis point for the selected level of analysis. 
 
Whilst the measures within the „bundle‟ are considered safe, adverse event 
data reported by each unit in their GRS reported were reviewed by the study 
team for any possible association with the measures in the „bundle‟. 
 
5.3. Results 
5.3.1. Global Results 
Data from 118 colonoscopists who had performed procedures during the 
baseline period were included in the analysis, as with the analysis for change 
in BR. Of the 4,351 procedures performed, a total of 698 procedures were 
found to have at least one adenoma during this period, translating to a global 
ADR of 16.0% (95% CI 15.0-17.2). In the period following the intervention, a 
total of 2,381 of the 13,157 procedures performed were found to have at least 
one adenoma resulting in a global ADR of 18.1% (95% CI 17.5-18.8). This 
increase in ADR was statistically significant (p=0.009).  
 
5.3.2. Unit level analysis 
At unit level, and increase in ADR was observed in 10 of the 12 units, with 
one (unit L) reaching statistical significance. Table 20 summarises the results 
per unit.  
 
Line graphs were produced to evaluate direction of change in ADR per 
colonoscopist within each unit, an example of which is shown in Figure 17. 
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This helps to demonstrate the challenge of analysing unit level data due to the 
heterogeneity that exists. Graphs for the remaining units are in Appendix L. 
Funnel plots were created for each unit, which are not shown here but can be 
found in Appendix M. 
 
Table 20: Summary of change in ADR in each unit together with the results of 
statistical analysis 
Before After 
Unit No. of 
procedures 
Patients 
with 
adenomas 
ADR 
(%) 
No .of 
procedures 
Patients 
with 
adenomas 
ADR 
(%) 
Ratio p 
value 
A 72 15 20.8 264 47 17.8 0.85 0.56 
B 275 34 12.4 745 124 16.6 1.35 0.09 
C 191 34 17.8 477 87 18.2 1.03 0.89 
D 247 25 10.1 729 106 14.5 1.44 0.08 
E 556 102 18.3 2073 371 17.9 0.98 0.81 
F 791 126 15.9 2153 346 16.1 1.01 0.92 
G 344 55 16.0 959 186 19.4 1.14 0.36 
H 465 86 18.5 1409 288 20.4 1.11 0.36 
I 379 58 15.3 1018 176 17.3 1.13 0.38 
J 235 43 18.3 612 113 18.5 1.01 0.96 
K 341 42 12.3 1173 182 15.5 1.26 0.14 
L 455 78 17.1 1545 355 23.0 1.35 0.008 
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Figure 17: Line graph of ADR before and after the intervention for each 
colonoscopist in unit E. 
 
 
5.3.3. Colonoscopist level analysis 
Because of the relatively low number of colonoscopies performed by some 
individuals endoscopists, a significant change in ADR was detected in only 5 
(4.2%), all of whom increased. The spread of ADRs per colonoscopist during 
the „before‟ and „after‟ period are shown in Figure 18 and Figure 19. 
 
In order to evaluate how these changes had affected the spread of data, 
funnel plots were created with respect to the global mean during the baseline 
of 15.9% (prior to application of inclusion/exclusion criteria). Graphs were 
created for all participating colonoscopists for the periods before and after the 
intervention as shown in Figure 20. There were more colonoscopists below 
the lower 95% limit after the intervention (12 vs.10) and more above the upper 
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95% limit (12 vs. 4) but these changes are not significant due to wide 
confidence intervals. The data also demonstrates with more confidence that 
there continue to be colonoscopists performing a large number of procedures 
(>100) whose ADR is below the lower confidence limit. 
 
Figure 18: Summary of the ADRs per colonoscopist during baseline period 
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Figure 19: Summary of the ADRs per colonoscopist during the period 
following the intervention 
 
 
Figure 20: Funnel plot of ADRs of all colonoscopists during the period a) 
before and b) after the intervention with respect to the baseline mean. 
a) 
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b) 
 
 
5.3.4. Quartile Analyses 
Analyses by quartiles were performed to better understand whether the 
„bundle‟ influenced the ADR of individuals differently depending on their 
baseline performance. Following exclusion of colonoscopists performing fewer 
than 25 procedures during the period before the intervention, a total of 68 
remained that were included in these analyses. This included 25 (36.8%) 
consultant gastroenterologists, 20 (29.4%) consultant surgeons, 12 (17.6%) 
nurse endoscopists, 7 (10.3%) trainees in gastroenterology 1 (1.5%) 
geriatrician, 1 (1.5%) GP and 2 (3.0%) non-consultant grade staff members. 
The number in each quartile is shown in Table 21. 
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Table 21: Breakdown of each quartile by colonoscopist speciality 
Speciality Upper Upper Middle Lower Middle Lower 
Gastroenterologist 8 8 4 5 
Surgeon 2 4 8 6 
Nurse 4 3 3 2 
Trainee 2 2 1 2 
Geriatrician 0 0 1 0 
GP 0 0 0 1 
Non-consultant 
grade 
0 0 0 2 
 
Following implementation of the „bundle‟, there was a significant improvement 
in ADR in the lower and lower middle quartiles. There was also an 
improvement in ADR in the upper middle quartile although this did not reach 
statistical significance. The ADR of the upper quartile fell significantly, but was 
still 21.5% during the period after the intervention and still above the other 
quartiles. The results for ADR per quartile are summarised in Table 22.  
 
Table 22: Summary of change in ADR per quartile with the results of 
statistical analysis 
Before After 
Quartile N Patients 
with 
adenomas 
ADR 
(%) 
N Patients 
with 
adenomas 
ADR 
(%) 
Ratio p 
value 
Upper 785 215 27.4 2508 538 21.5 0.78 <0.001 
Upper 
Middle 
1116 195 17.5 3119 599 19.2 1.10 0.24 
Lower 
Middle 
785 104 13.2 2539 490 19.3 1.45 <0.001 
Lower 936 68 7.3 2405 334 13.9 1.91 <0.001 
N = number of colonoscopies 
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Additionally, the ADR of the respective quartiles before the intervention were 
all significantly different from one another. Following the intervention, only the 
lower quartile was significantly different from the remainder.  
 
Line graphs representing the direction of change in ADR for each quartile are 
shown in Figure 21 to Figure 24. Funnel plots for each quartile relative to the 
baseline mean are shown in Figure 25 to Figure 28. 
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Figure 21: Line graph showing direction of change in ADR for the lower 
quartile. 
 
 
Figure 22: Line graph showing direction of change in ADR for the lower 
middle quartile. 
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Figure 23: Line graph showing direction of change in ADR for the upper 
middle quartile. 
 
 
Figure 24: Line graph showing direction of change in ADR for the upper 
quartile. 
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Figure 25: Funnel plot for the lower quartile. 
 
 
Figure 26: Funnel plot for the lower middle quartile. 
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Figure 27: Funnel plot for the upper middle quartile. 
 
 
Figure 28: Funnel plot for the upper quartile. 
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5.3.5. Adverse events 
The study team reviewed all adverse events documented by each 
participating unit as part of their GRS reports for the period after the study 
intervention. There were no adverse events that were attributable to use of 
the „bundle‟ measures. 
 
5.4. Discussion 
We have shown in the previous chapter that the study intervention resulted in 
a significant increase in BR globally. This also resulted in a significant global 
increase in ADR (16.0 % vs. 18.1%). 
 
All units demonstrated a significant increase in their BR with the proportion of 
colonoscopists per unit showing an increase ranging from 41.7% to 83.3%. 
Despite this level of adoption, only one unit demonstrated a significant 
increase in ADR. It is likely that the number of procedures performed within 
each unit is a major reason for the increase in ADR not achieving statistical 
significance. Another important consideration is that each unit is made up of 
colonoscopists whose performance varies greatly as indicated by the 
individual values of ADR. This is most evident on the unit level funnel plots 
and line graphs (Appendices L and M). The reason this is so important is that 
not all colonoscopists had the same potential or room to improve. 
Colonoscopists achieving the highest ADRs had much less chance of 
improving further as the ADR is limited by the prevalence of adenomas in the 
population being colonoscoped. Those who had been performing poorly had 
the greatest capacity for improvement. Any positive movement observed 
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among those performing poorly at baseline may be counter balanced by a 
lack of significant movement or a slight fall in those performing well at 
baseline. This concept is clearly illustrated in the line graphs summarising 
movement in ADR between the before and after periods and also in the 
quartile data as discussed below. 
 
Among the 118 colonoscopists whose data were included in our analyses, at 
least 61.0% were judged to have changed practice in line with the aims of the 
improvement bundle as evidenced by a significant increase in their BR.  In 
terms of how this affected their ADR, analysis of results has to take into 
account common cause variation. The numbers required to do this for 
individual colonoscopists is large as presented earlier in this chapter. The 
number of procedures performed by some colonoscopist was very low, 
especially during the baseline period. Despite this, five colonoscopists (4.2%) 
did exhibit a significant increase in ADR. Although the majority of 
colonoscopists performed too few examinations to allow a statistically 
significant result to be demonstrated at the level of the individual, the use of 
funnel plots did allow visual comparison relative to the selected reference 
standard of 15.9% (the baseline mean prior to application of the 
inclusion/exclusion criteria for comparative analyses). There were more 
colonoscopists above the upper 95% limit but also more below the lower 95% 
limit than prior to implementation of the improvement bundle. We must 
appreciate, as highlighted in chapter two, that each colonoscopists ADR has 
its own 95% CI that may cross the limits of the funnel plot. However, the 
movement observed may indicate that, whilst a statistically significant 
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improvement was not demonstrated, there was a genuine improvement in 
ADR at colonoscopist level following the intervention. The graphs do also 
highlight that there continued to be some poorly performing colonoscopists 
that must be addressed. Finally, we must also remember that quality 
assurance is a continuous process and that ongoing monitoring is required to 
ensure positive changes continue and high performers maintain their 
standards. 
 
Quality improvement programmes are tasked with improving overall quality, 
although those who are under performing clearly have the most room for 
improvement. When quartiles were constructed by ranking colonoscopists 
according to their baseline ADR and cumulating their results, the outcomes 
were very interesting. A significant increase in BR was seen within all four 
quartiles suggesting a good uptake amongst all. A significant improvement in 
ADR was seen in the lower two quartiles as might be anticipated if the uptake 
of the bundle was successful. However, there was also an increase in ADR in 
the upper middle quartile, which failed to reach statistical significance for the 
numbers studied. In the upper quartile, the ADR fell significantly to 21.5%. 
This value remained above the ADR for the remaining quartiles and the global 
mean following the intervention (18.1%). Furthermore, the ADR of the upper 
quartile both before and after implementation was above 20%, the value 
below which Kaminski‟s data suggested a higher rate of interval cancer and 
also the criteria for entry to be eligible to participate in most screening 
programmes. (7, 25) This suggests that quality within the upper quartile was 
still very high. Importantly, there was also a reduction in variation in ADR 
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observed before the intervention with only the lower quartile remaining 
significantly different from the others. 
 
The data for the quartiles were the cumulative results of the colonoscopists 
within each group. This method provides useful information regarding the 
general movement of each group but does not take into account the variation 
of each of the colonoscopists within it. Analysing the funnel plots for each 
quartile, in conjunction with the cumulative data, provides additional 
information. For the upper quartile, the funnel plot for the group shows that the 
movement was within the funnel with no colonoscopists falling below the 
lower limit. Examination of the remaining quartiles shows that there are more 
colonoscopists above the upper 95% limit following the intervention for each 
quartile. In the lower quartile, there were also fewer colonoscopists below the 
lower 95% limit.  In the lower middle quartile, one colonoscopist fell below the 
lower 95% limit. 
 
When taken together, analysis of the cumulative data and the funnel plots 
demonstrate an improvement in ADR for the lower two quartiles resulting in a 
reduction in the variation observed before the intervention. The fall in the ADR 
within the upper quartile was not clinically significant as the rate remained well 
above the baseline and post-intervention means, the 20% criteria for 
screening colonoscopists and that suggested by Kaminski et al and all 
remained above the lower 95% confidence limit. The small number of 
colonoscopists who remain below the lower 95% limit should now be identified 
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confidentially and helped to improve their performance in order to improve 
patient care. 
 
The global increase in ADR was 2.1% the clinical significance of which can be 
debated. In a recent study, the association between a colonoscopists ADR 
and subsequent CRC risk and cancer-related death was evaluated by Corley 
et al. (74) This study demonstrated that a 1% increase in ADR may lead to a 
3% decreased risk of interval CRC. This suggests that even a small increase 
in ADR may be clinically significant. It must again be emphasised that the 
2.1% improvement observed is a cumulative global improvement that, if 
considered in isolation, underestimates more significant changes amongst 
colonoscopist sub-groups. This is clearly observed when examining the 
quartile level data as described above. For those colonoscopists with below 
average ADRs, the improvements were in the region of 6% and so it is this 
group where patients are likely to benefit most.   
 
Another consideration when evaluating the effect of our bundle on ADR at all 
levels is that, whilst the measures in our „bundle‟ provide the optimal 
conditions for adenomas present to be detected, the colonoscopists own 
withdrawal technique and diligence towards adenoma detection must still 
ultimately be relied upon as has been previously demonstrated. (31, 32) 
Training on optimal examination technique was outside the remit of this study 
primarily due to the time required. This is one area that could be addressed 
among colonoscopists that continue to fall below national requirements.  
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Regarding the values for ADR observed in this study we must remember that 
this was a general symptomatic population with all NHS BCSP patients, in 
whom the prevalence of adenomas is much higher, excluded. The recent 
British Society of Gastroenterology (BSG) UK colonoscopy audit revealed the 
global PDR to be 32.1% which is likely to translate to an ADR of 
approximately 20%. (75)  Another large UK study, as discussed in chapter 2, 
reported a global ADR of 19.2%. (46) Both studies included data from BCSP 
patients. It is, therefore, probable that a mean ADR of approximately 18% is 
reasonable to expect for a UK symptomatic population at present. We should, 
none the less, aspire to improve upon this in the near future especially given 
the mean age of patients colonoscoped by the majority of colonoscopists in 
this study. 
 
The results of this and other studies further highlight the differences in ADR 
between the symptomatic and screening populations. Lee et al reported the 
results from the first 3 years of the NHS BCSP revealing a mean ADR per 
colonoscopist of 46.5% (range 21.9% to 59.8%). (8, 38) There are several 
possible reasons for this including the prevalence of adenomas within this 
population selected by positive FOB testing and the structure of the screening 
programme and lists. (8) It is also possible that BCSP colonoscopists, through 
increased exposure, may become more skilled at detecting small adenomas.  
Whilst it would have been difficult to evaluate accurately within this study due 
to the number of other variables, it would be useful to compare differences in 
performance of BSCP and non-BCSP colonoscopists within a similar 
symptomatic population in future work to better understand potential 
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differences in colonoscopy technique that could, if present, be incorporated 
into future quality improvement initiatives. 
 
Colonoscopy performance in the UK has improved significantly over the last 
10 years largely through improvements in completion rates and sedation 
practice. Despite this the incidence of CRC has not changed significantly. (76) 
Whilst improvements in ADR and PDR have occurred, there continues to be 
considerable variation in this performance metric and thereby mucosal 
evaluation. This is demonstrated clearly in our baseline data in Chapter 2, and 
whilst our intervention reduced variation in ADR, there continues to be a 
proportion of colonoscopists whose ADR is well below average. This is one 
factor explaining why there has not been a change in CRC incidence despite 
improvements in CIR. Other factors include the continued variability in 
detection of sessile lesions, particularly sessile serrated adenomas, and a 
relatively recent paradigm shift in their management. (77-79) Another problem 
relates to the high proportion of patients with poor bowel preparation. (75) The 
results of this study suggest that our intervention may help to reduce variation 
in ADRs, however, further work is required to ensure all colonoscopists 
achieve and maintain acceptable ADRs and to address the other factors 
discussed.  
 
In summary, a significant increase in ADR was observed globally. The ADR 
among the lower two quartiles significantly improved and this resulted in a 
significant reduction in the variation observed prior to the intervention 
suggesting an improvement in colonoscopy quality. It is also important to re-
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iterate that the intervention in this study was multi-faceted including an 
educational visit, use of the „bundle‟ measures and feedback. The potential 
contributions and influence of these factors have been discussed in chapter 4 
and will be debated further in the remaining chapters. 
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Chapter Six: Factors Influencing Uptake of Evidence – A 
Qualitative Evaluation 
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Chapter Six: Factors Influencing Uptake of Evidence – A Qualitative 
Evaluation 
6.1. Introduction 
Although evidence based practice is widely recommended, the introduction of 
evidence into clinical practice can be challenging. (80) Implementation models 
are often ill conceived and non-evidence based. (55) Traditional methods 
optimistically relied upon passive diffusion of published research and 
guidelines, assuming that clinicians would read and integrate new evidence 
into their practice with relatively little prompting. Whilst more active models 
have been adopted more recently, their impact is still variable. (57) Reasons 
include a failure to recognise and address common barriers to 
implementation. (55) For this study, the identification of barriers and 
facilitators to implementation was performed during the development phase of 
our model. Despite uptake being good, it was not universal.  
 
Identifying factors that facilitate or constrain uptake of evidence into clinical 
practice is vital to allow a greater understanding of which components of a 
given implementation model are most useful. In order to identify such factors 
present during the QIC study, a qualitative interview evaluation was 
performed with members of the endoscopy units who participated to explore 
experiences of introducing innovative practice in a routine clinical setting.  
 
6.2. Methods 
The qualitative evaluation was conducted following completion of the clinical 
study. Semi-structured, face to face interviews were carried out with study 
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leads, colonoscopists and endoscopy nurses, in a purposive sample of the 
units taking part in the study. This enabled issues to be examined from 
differing perspectives and to explore how innovation and change filters 
through organisations, altering during that process from the original intention. 
 
Units were purposively sampled to ensure that those with the biggest and 
smallest changes in ADR (using preliminary data from the feedback provided 
at four to six months) were included. A big change was defined as a 
difference in ADR of ≥ 2.5%. Units doing a large number of colonoscopies and 
those doing fewer were also sampled, to explore whether issues such as 
workload and familiarity with new procedures influence the success or 
otherwise of uptake of the bundle.  
 
Interviews took place in the workplace but in an office away from other 
members of staff to enable confidentiality to be maintained. The interviews 
were recorded, with the consent of the interviewees, and later fully 
transcribed. All interviews were conducted within six months of completion of 
the clinical arm of the study to reduce recall bias and were continued until 
saturation had been reached. Interviews were conducted by a member of the 
qualitative evaluation team (Dr Cath Nixon) who had not been part of the QIC 
implementation team. This was in order to reduce bias that may have been 
introduced had a member of the original team conducted the interviews. The 
structure of the interview was based on the “theoretical domains interview” 
developed by Michie et al and further developed by Francis et al. (81, 82) 
Interviews explored how the training was organised and delivered, who 
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attended and how those who could not attend the training sessions were 
instructed in the bundle. Variations in the use of the bundle included whether 
feedback was given, as well as why and how feedback about performance 
influenced the individual colonoscopist. 
 
Thematic analysis was used to code and categorise the interviews, and to 
develop a framework for analysis. Two members of the study team (Dr Sally 
Brown and I) analysed a proportion of transcripts independently and agreed 
upon the framework. I subsequently used the agreed framework to re-analyse 
the initial and remaining transcripts. The themes identified were: time; study 
promotion; training; engagement; positive outcomes; modifications. 
 
Study Registration 
The qualitative evaluation was registered at all participating units thorough the 
audit or research and development departments as required. 
 
Ethical Approval 
Ethical approval for the qualitative evaluation was granted following review by 
the Durham University School of Medicine, Pharmacy and Health Research 
Ethics Committee (Appendix N). 
 
6.3. Results 
A total of eleven participants in the QIC study agreed to be interviewed. There 
were seven lead colonoscopists, one lead nurse and three colonoscopists that 
were not leads. There were six participants from larger units and five from 
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smaller units. Five colonoscopists were from units in which a large change in 
ADR was observed and six from units in which smaller changes were seen. 
All interviews were concluded by approximately six months after completion of 
the quantitative arm of the study. Quotations from interviewees are labelled 
with their QIC code and their role within the study. Therefore, QIC 01/lead 
colonoscopist is for QIC 01 who was a lead colonoscopist within the study. 
 
Time 
Time had been identified as a potential barrier to uptake during development 
of the implementation model. This was confirmed during this evaluation. It was 
reported that time pressures led to difficulty finding a suitable time and forum 
for local training sessions leading to limited attendance in some units. This 
necessitated multiple visits when feasible. The fact that there were multiple 
opportunities to attend the training was reported positively, however, this 
approach is less likely to be feasible outside the setting of this study. 
 
“it is difficult in the NHS to get everyone into one room” (QIC128/lead 
colonoscopist) 
 
“I think having multi-choice access to training is always a good idea 
because, you know, you can‟t guarantee everyone is going to be in one 
place at one time” (QIC118/colonoscopist, non-lead) 
 
Time was also a factor when implementing the „bundle‟ into colonoscopy 
practice. It was reported that this was given as a reason for non-engagement 
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by some colonoscopists. However, this appeared not to be reflected in 
practice as it was reported that endoscopy lists continued to run to time during 
the study. The simple nature of the „bundle‟ was also reported as a reason for 
engagement. 
 
“I don‟t think we‟ve seen any sort of unintended consequences of the 
study. I don‟t think we saw the lists fall apart or that the patients were 
being disadvantaged in any way” (QIC111/lead colonoscopist) 
 
“if it had taken, if it involved a lot of input from me I would have been 
less inclined to take part” (QIC125/colonoscopist, non-lead) 
 
Study Promotion 
Leads for the study appeared to embrace their role in promoting and engaging 
colonoscopists within the study. Several methods were used, including regular 
e-mails, face to face meetings and using forums such as directorate meetings. 
A novel approach was used by one lead who took the opportunity to promote 
the study during the local approvals process required to erect posters in 
clinical areas. Leads also found the monthly e-mail contact from the study 
team helpful. It was also apparent that non-lead colonoscopists also became 
involved in study promotion indicating wider spread enthusiasm for the 
project. 
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“following his sort of one hour training presentation to us we discussed 
it locally within our unit and our, we have a two monthly endoscopy 
user group meetings” (QIC01/lead colonoscopist) 
 
“it was just making people aware of it and then reinforcing” 
(QIC118/colonoscopist, non-lead) 
 
It was reported by two lead colonoscopists that there was some confusion 
over the level of promotion that they were required to undertake, their concern 
being that this could interfere with the results of the study. This is certainly one 
area in which delivery of the central training could have been improved. 
 
“Yes yes, I guess the level of ongoing input cajoling and so on wasn‟t, I 
wasn‟t that clear, I didn‟t want to interfere too much, you know” 
(QIC43/lead colonoscopist) 
 
Endoscopy nurses were identified early on as potential facilitators for uptake 
of the „bundle‟ and efforts were made to engage and empower them to 
promote the study before its commencement. This appeared to bear fruit as it 
was consistently reported that the endoscopy nurses did actively promote the 
study. This included referring to the study poster, ensuring Buscopan was 
readily available and reminding colonoscopists when it was due to be given. 
Nurses also took it upon themselves to warn patients that rectal retroflexion 
was about to be performed thereby reminding the colonoscopists as well. This 
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was an important finding of this evaluation and provides powerful evidence 
regarding how change within an endoscopy unit can be achieved. 
 
“quite often now when I get to the caecum the nurse will say „Do you 
want to give Buscopan?‟ so you know the nurses are prompting us” 
(QIC43/lead colonoscopist) 
 
The study posters were also reported to be very useful in reminding 
colonoscopists to use the „bundle‟. The design was described as simple and 
high impact and also provided a method that endoscopy nurses could use to 
promote the study.  
 
“I think the biggest thing to help that was the big posters on the wall 
saying for the QIC study please remember” (QIC122/lead 
colonoscopist) 
 
Training 
It was also recognised that training should be short and study documents 
simple in order to maximise engagement. The local training sessions were felt 
to have been delivered well and the PowerPoint presentation appropriate. The 
study documents were also reported have been the suitable.  
 
“I mean the slides were well made so it was quite easy to understand 
and for the main training that (PTR) delivered I think it was quite good 
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because there was time to ask questions so we did manage to sort of 
ask questions” (QIC128/lead colonoscopist) 
 
Some colonoscopists were not keen to perform rectal retroflexion for reasons 
including the potential for discomfort for the patient and that it can be a difficult 
to perform the manoeuvre if unfamiliar with the technique. The training 
included a video demonstration of how to perform retroflexion. However, there 
was no provision for „hands on‟ training either during or following local training 
sessions. This draws attention to the need to consider training when 
implementing evidence into clinical practice. 
 
Whilst the training sessions were felt to have been well conducted, it was 
suggested that a research fellow may not have been a „big draw‟ for those 
who may have been less engaged to begin with. In contrast, it was reported 
that units in which the research fellow had previously worked and developed 
good relationships may have been more engaged for this reason. It was also 
suggested that the training for the endoscopy nurses could have been 
performed by a clinical nurse or sister. These data suggest that consideration 
should be given to who delivers the teaching to different subgroups. 
 
“I think that nursing staff probably like a clinical nurse or a clinical sister 
or an endoscopy nurse consultant to come and do the training... the 
feeling they get when a consultant comes along is it‟s a job to be done 
and it is going to be put on to us we have got no choice, we have to do 
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it and that‟s somewhat the wrong kind of way to do it.” (QIC128/lead 
colonoscopist) 
 
Engagement 
Engagement was good but not universal. Generally, uptake among 
gastroenterologists and nurse endoscopists was reported as good, however, 
was less so among surgical colonoscopists. It was also reported that more 
junior colonoscopists and trainees were more engaged with the study. 
 
The study promotion, as discussed above, was an important factor in 
encouraging engagement, as was the simple nature of the „bundle‟. Other 
reasons included the fact that the study had been conceived by leaders in the 
field of colonoscopy.  
 
“I guess the fact that the trial was developed in conjunction with, you 
know, some of the national experts in colonoscopy, helped” 
(QIC111/lead colonoscopist) 
 
It was also reported that the longer the „bundle‟ was used, the more it became 
embedded into practice. 
 
“and I think because the study‟s gone on for so long- like for a year, it‟s 
kind of embedded those things into practice... and the more you do it, 
the more it becomes a routine and you know it just sticks” 
(QIC122/lead colonoscopist) 
 140 
 
The feedback provided was thought to very useful. In one unit, it was reported 
that some of the surgical colonoscopists who were sceptical, engaged more 
with the study following the feedback demonstrating that their unit had 
improved. 
 
“surgeons found it very interesting that these kind of things make a 
difference” (QIC23/lead colonoscopist) 
 
The colonoscopists interviewed reported a change in their own practice. In 
particular, an increased awareness of withdrawal time was highlighted. The 
use of Buscopan also increased. One lead commented that they were now 
more attentive to the detection of small polyps as the training had highlighted 
the importance of this as a quality marker. 
 
“For me I think it‟s probably just made me think about it more... and the 
six minute withdrawal, well I never timed myself to be honest so I am a 
bit more conscious about that” (QIC55/colonoscopist, non-lead) 
 
I have been more cognizant of the fact that it matters to detect small 
polyps” (QIC102/lead colonoscopist) 
 
There were several reasons suggested for poor engagement. These included 
scepticism over whether the „bundle‟ in its entirety would increase ADR and 
also the value of certain components of the „bundle‟. As discussed above, the 
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potential for retroflexion to cause patient discomfort and inexperience with the 
manoeuvre were also reasons.  
 
“the Buscopan was the one where a lot of people weren‟t convinced it 
was going to add to polyp detection but most of them were probably 
surgeons” (QIC128/lead colonoscopist) 
 
Specifically regarding surgeons, reasons stated for possible poor engagement 
included general reluctance to consider changing their practice, being less 
reflective in their practice and their perception that the „bundle‟ would only 
lead to increased detection of small, less clinically significant lesions. The 
significance of ADR as a marker of a thorough colonoscopic assessment and 
the clinical significance of an individual adenoma was discussed during local 
training, however, this comment suggests it was incompletely understood. It 
was also suggested that surgeons may consider colonoscopy less of a priority 
than physicians due to their other commitments. 
 
“I think we‟ve got certain people who are not reflective in their practice 
and so would not see the benefit in it to them of changing” 
(QIC111/lead colonoscopist) 
 
“I sort of look at it as they‟ve (surgeons) got bigger fish to fry in their 
minds” (QIC01/lead colonoscopist) 
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Positive outcomes 
There were several positive outcomes described. The general increased 
awareness of quality in colonoscopy within the whole endoscopy unit was a 
major positive. This included the involvement and empowerment of the 
endoscopy nurses in promoting the use of quality measures and more closely 
observing procedures. This also highlights how change filters through an 
endoscopy unit. The success of the implementation model itself was seen as 
the most interesting outcome by one lead. 
 
“I mean when the whole unit is aware that these things make a 
difference” (QIC23/lead colonoscopist) 
 
“I think for me is the proof of concept almost, the, for me the most 
positive thing was that across the region we had individuals who were 
willing to embrace this and to try and disseminate this information, and 
we followed it through and we were all agreed” (QIC43/lead 
colonoscopist) 
 
The challenge of engaging certain specialties in the study was regarded as a 
positive outcome by one lead colonoscopist who stated that this prompted the 
whole unit to consider how they should approach similar issues in the future. 
Whilst this wasn‟t an aim of the study, it was an interesting additional 
outcome. 
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“it shone a light really on to working out how we deal with situations 
where people aren‟t willing to take on new agendas or quality markers 
and what our response to that should be” (QIC111/lead 
colonoscopist) 
 
Modifications 
The interviewees were also asked their thoughts on how the implementation 
process used in QIC study could have been improved. One challenge was the 
limited attendance at set up meetings. Suggestions to improve attendance 
was to attach sessions to other well attended meetings, especially surgical 
directorate meetings, and consideration of making such initiatives mandatory 
although a note of caution was also added to this suggestion on the grounds 
that it had the potential to antagonise.  
 
“we could make those mandatory, I mean it‟s just difficult because at 
the moment with all of the service pressure stuff…you‟ve got to be 
quite careful about doing is making too many things mandatory that 
turn people off” (QIC01/lead colonoscopist) 
 
It was also suggested that a well known speaker may encourage attendance 
at local training sessions particularly in groups that may have been less likely 
to engage with the study. 
 
The interviewees were from units of varied size and that had demonstrated 
varying levels of change in ADR during the initial feedback sessions. There 
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appeared to be no discernable differences in positive or negative aspects of 
implementation by size of unit or level of engagement, with the themes 
identified being consistent among all participants in this evaluation.  
 
6.4. Discussion 
Successful implementation of evidence of into clinical practice requires 
identifying and overcoming barriers to implementation. (55) An endoscopy unit 
is a complex system with many interacting components that can influence the 
running of a list and can, as a result, effect adenoma detection. Factors can 
be patient related or organisational. Therefore, interventions may have 
unexpected influences outside of the intent of the project and, as a result, 
unintended effects that cannot be anticipated or measured.  
 
The implementation model utilised in this study was multi-faceted, selected as 
similar models have been shown to be successful in other clinical settings. 
(64)  It is also natural to ask which components of the intervention produced 
the changes in ADR observed? This is of particular relevance if there are 
plans to replicate this model of implementation. For example, if we simply 
asked all UK colonoscopists to use the measures in the „bundle‟, would this 
produce the same results observed in this study? 
 
The time pressures within endoscopy units were identified as a potential 
barrier to implementation and this appeared to be the case in practice as 
evidenced by limited attendance at local training sessions with time pressure 
given as a likely reason. The comments regarding how the „bundle‟ may 
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prolong procedure time (whilst this was not the case in practice) also support 
this concept. Suggested solutions included associating sessions with other 
well attended meetings, making them mandatory or inviting well known 
speakers to present.  
 
In the context of the QIC study it would not have been possible to make use of 
the „bundle‟ mandatory. However, ensuring that the medical directors were 
aware that a large scale quality improvement programme was underway in the 
trust was also one method used to encourage uptake. Associating training 
sessions with other meeting is certainly one method that should be 
considered for future initiatives. The use of a more senior member of the study 
team to lead local training sessions was discussed during design of the 
implementation model although this would not be logistically possible given 
the number of sessions that would be required. This strategy could be 
considered in other settings, however, it is likely that the same logistical 
challenges would apply. The fact that multiple sessions were conducted at 
some units was described as a positive feature but again this approach is 
unlikely to be feasible outside of the setting of a study. 
 
It had also been predicted that surgical colonoscopists might engage poorly 
with the study, which was perceived to be the case in all units. It appeared 
that this was not adequately addressed during implementation of the „bundle‟. 
One reason for this was that the QIC study was designed to be pragmatic. A 
more complex implementation model, such as surgeons presenting to 
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surgeons, may have increased general uptake, but would have been less 
reproducible in routine endoscopy practice.  
 
It was also reported that junior colonoscopists appeared to be more engaged 
with the study than more experienced staff. This concept has also been 
reported previously. (63) It is possible that a better known speaker may have 
more gravitas with more senior staff - another reason for considering this 
approach where feasible. 
 
It has been reported that complex interventions are less likely to be integrated 
into clinical practice. (57, 60) This is supported by the findings of this study 
where the simple nature of the „bundle‟ was easily integrated into colonoscopy 
practice encouraging uptake. Interestingly, it was reported that continued use 
of the „bundle‟ led to it becoming embedded in routine practice and almost 
second nature. This, in part, is also likely to be as a result of the simple nature 
of the „bundle‟ and continued study promotion.  
 
It was reported that the potential discomfort caused by rectal retroflexion was 
a concern. The ideal technique that should be used to perform retroflexion 
was covered during the local training sessions and in the study DVD. There 
was, however, no provision for additional „hands on‟ training for 
colonoscopists that were remained uncomfortable performing the manoeuvre. 
This is a negative aspect of shorter training sessions. Whilst additional training 
would not have been possible in the context of this study, this does draw 
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attention to the fact that adequate steps to ensure training for those that may 
require it, should be given some consideration in future initiatives. 
 
Study promotion was well conducted with several methods utilised such as e-
mails, face to face meetings and discussion at directorate meetings, 
successfully engaging the majority of colonoscopists. It is known that 
guidelines that are visible are more likely to be used. (63) The findings of this 
study support this with the highly visible posters described as a major factor 
promoting uptake.  
 
It was recognised during study development that the endoscopy nurses were 
potential facilitators for uptake and this also proved to be the case with the 
role of the endoscopy nurses in study promotion consistently reported as a 
positive outcome. It was also suggested that, had a clinical sister delivered 
the training, it may have further enhanced engagement among endoscopy 
nurses. This highlights the importance of identifying facilitators for 
implementation and also those who should deliver training sessions. 
 
The study was conceived and developed by colonoscopists who are 
considered leaders in the field. This was reported as a factor that would have 
positively influenced engagement. The use of opinion leaders is a strategy 
that has been shown to positively influence professional behaviour and is 
supported by our findings. (83) 
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Feedback and knowledge of peer performance is known to improve 
performance in a variety of settings. (84) This was confirmed by the findings of 
this study with feedback reported to be an important aspect of the 
implementation model. Furthermore, colonoscopists that were sceptical about 
the study were felt to have been engaged by the feedback provided. 
 
A major positive outcome of the initiative was to successfully raise awareness 
of the importance of quality in colonoscopy in endoscopy units as a whole 
through the inclusive nature of the implementation model. This included 
empowering endoscopy nurses to encourage the use of quality measures. 
Inclusivity has been shown to improve uptake of protocols and guidelines and 
is very likely to have contributed to success of this study.  (63) A positive 
outcome that was not envisaged was highlighting methods to engage 
sceptical individuals. This demonstrates the importance of analysing the 
results of implementation models, as unpredicted outcomes can result and 
these may be useful in other settings. 
 
One factor that may have contributed to poor engagement was the scepticism 
as to whether the „bundle‟ would significantly increase ADR. The concept 
behind this study included the thought that, whilst each measure in isolation 
may have produced a small effect, their use in combination may produce a 
more pronounced effect. Whilst doubts regarding this are valid, we must 
consider that this was a study to test a hypothesis rather than a categorical 
statement that the „bundle‟ would definitely improve ADR.  
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The themes that emerged were consistent throughout all participants. There 
appeared to be no differences in themes when considering units by size or 
change in ADR. This suggests that the findings of this evaluation will be 
generalisable to the majority of endoscopy units. 
 
A limitation of this work is that the majority of interviewees were lead 
colonoscopists or nurses who were more likely to have been engaged with the 
study. Furthermore, all but one were medical colonoscopists with only one 
surgical colonoscopist interviewed. This potential for bias must be borne in 
mind in particular when considering opinions regarding the challenges of 
engaging surgeons. It must be added that repeated attempts were made to 
contact and arrange interviews with clinicians who had been less enthusiastic 
about implementing the initiative to better understand reasons for non-
engagement, however it was not possible to secure an interview. This is a 
common challenge faced in qualitative research and is a difficult problem to 
solve. 
 
In summary, several factors are likely to have influenced the changes in ADR 
observed in the study outside of the measures within the „bundle‟. This is 
important to appreciate in any attempt to replicate the intervention. The 
experience of the QIC study suggests that interventions should be simple, 
supported by good, inclusive, local promotion and should include feedback. 
Identifying facilitators to implementation is crucial and can significantly 
influence engagement. Strategies to engage groups less likely to participate 
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should be developed at the outset of the implementation process. Provision 
for additional training, where feasible, should also be given consideration. 
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Chapter Seven: Summary, limitations, key findings and 
future work 
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Chapter Seven: Summary, limitations, key findings and future work 
7.1. Thesis Summary 
Chapter one discusses the current prevalence of colorectal cancer (CRC) and 
the resulting morbidity and mortality. It summarises current knowledge that the 
majority of sporadic CRCs develop from adenomas and that their detection 
and removal at colonoscopy can significantly reduce the incidence of CRC. 
The variability in colonoscopy quality is demonstrated in terms of adenoma 
detection and also how missing such lesions may expose patients to 
increased risk of interval cancer. The conclusion is that the quality of 
colonoscopy needs to improve forming the premise upon which this service 
improvement study is based.  
 
Chapter two discusses the setting in which the QIC study took place, the 
Northern Region Endoscopy Group (NREG), and the reasons it was selected. 
The performance during the baseline period (three month period before the 
study intervention) was analysed in detail. The results showed that the caecal 
intubation rates (CIR) were of an acceptable standard but that there was an 
unacceptable variation in adenoma detection rate (ADR). Furthermore, the 
current 10% standard for ADR suggested by the British Society of 
Gastroenterology (BSG) is too low and if used as a reference standard for this 
study would result in inappropriate analyses and conclusions. The mean ADR 
of 15.9% observed during the baseline period was felt to be a much more 
appropriate reference standard. These data confirm that there is room to 
improve ADR within NREG and also that the national standard for ADR should 
be increased to at least 15%. 
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In chapter three, methods of improving adenoma detection are discussed. 
The challenges of implementing evidence into clinical practice are also 
reviewed, including methods of how barriers can be overcome. An example of 
an implementation model that succeeded in improving central line 
management in an intensive care setting is presented (Pronovost et al). 
Having demonstrated unacceptable variation in ADR, the hypothesis 
presented in this chapter is that implementation of the measures discussed 
could be feasible and result in an increase in ADR using a similar model to 
Pronovost‟s group 
 
Chapter four outlines how the model of implementation was designed taking 
into account the factors discussed in the preceding chapter. All facets of the 
implementation model are discussed in detail including additions that were 
made after potential barriers were identified. The changes in practice following 
the intervention are presented, demonstrating a good uptake at the level of 
the individual colonoscopist, endoscopy unit and across the whole of Northern 
Region.  The results are compared to other studies in which educational 
interventions were utilised. Limitations including use of a surrogate marker for 
uptake are discussed. The results indicate that the intervention utilised in the 
QIC study resulted in a significant change in clinical practice for the majority 
(but not all) of the colonoscopists in the study. Compared with the results of 
studies utilising similar models of implementation, we can describe the uptake 
of the measures as “good”. 
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In chapter five, the effect of the change in practice on ADR are presented and 
discussed. There was limited change observed at the level of the 
colonoscopist and unit, the probable reasons for which are discussed. 
Importantly, a significant improvement was observed in the lower two quartiles 
resulting in a significant reduction in variation after the intervention. The fall 
observed in the upper quartile is discussed and how and why this is unlikely to 
represent a clinically significant fall. Limitations are discussed, including low 
procedure numbers in the individual and unit level analyses. We conclude that 
the intervention (educational visit, „bundle‟ measures, promotion and 
feedback) may be particularly useful among colonoscopists whose ADR is 
below the baseline mean of 15.9% and could reduce variation. Further 
controlled studies required to confirm these findings. 
 
Chapter six explores factors that facilitated and constrained implementation of 
the „bundle‟ into clinical practice. Colonoscopists and endoscopy nurses that 
took part in the QIC study were invited to participate in semi-structured 
interviews that were utilised to collect the data that was evaluated using 
thematic analysis. Positive themes included the general increased awareness 
of quality in colonoscopy throughout units, the positive influence of endoscopy 
nurses in promoting quality measures, the usefulness of the simple study 
poster and the importance of feedback. Challenges included restricted time 
within the NHS for meetings and during endoscopy lists and engaging surgical 
colonoscopists. The results highlighted the importance of developing 
strategies to engage such groups at the outset of any quality improvement 
interventions. This also highlight that factors outside use of the „bundle‟ are 
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likely to have influenced the changes observed and must be considered if 
wider roll out is to be considered. 
 
7.2. Limitations of the study 
All studies have limitations that are important to consider when interpreting 
results. The possible implications for the observations in this study will be 
discussed and also why certain limitations had to be accepted for this 
particular project. 
 
7.2.1. Study design and other factors 
The QIC study was intended to be a large scale, pragmatic service 
improvement study aiming to encourage evidenced-based best colonoscopy 
practice as routine thereby improving overall quality. The hypothesis was that 
if measures to increase mucosal visualisation could be incorporated into 
routine colonoscopy practice, then following on from this, more adenomas 
would be detected compared to if no intervention had occurred. Introduction of 
the „bundle‟ was supported by an educational visit, promotion and feedback. 
Service improvement work involves introducing change into complex, „real 
world‟ settings or systems, often with minimal resources. As a result, 
interventions must be simple, cause minimal disruption to existing systems 
and, importantly, be both time and cost effective. (63) An overly complicated 
or complex intervention runs the risk of not being adopted during the study 
phase and if wider implementation is required. Service improvement work 
must, therefore, often take a pragmatic approach. Furthermore, such projects 
must be continuous, often iterative processes. A benefit of this type of work is 
 156 
 
that it is potentially more widely reproducible in contrast to more tightly 
controlled research studies. A limitation is that the often numerous variables, 
particularly in multi-centre studies, can make interpretation of results 
challenging. 
 
In our study we did not randomise which units underwent the intervention nor 
did we have a control group. When deciding upon our methodology, the use 
of a randomised control design was considered. Prior to this, the study had 
been classified as a service improvement project in which all units would 
receive the intervention as the measures are considered by many to be best 
practice. As such, our local research ethics committee chairman had stated 
we did not need ethical approval to perform the study. For this pragmatic 
reason, we were unable to stipulate that some units would not receive the 
intervention without invalidating this statement. An alternative that was 
considered was to use a randomised stepped approach to implementation. 
This has the advantage of providing some units who would not have 
undergone the training to act as controls. This approach would also have 
provided a few challenges. Firstly, units entering later in the study would have 
less exposure to it resulting in fewer procedure numbers during this stage. 
This would have further reduced the power to detect a significant change, 
particularly in ADR, as has been discussed. Secondly, some units that work 
independently are actually part of the same NHS trust. This would have 
proved a logistical difficulty to the implementation process, as there would 
have been a risk of units becoming aware of the components of the 
intervention „bundle‟ prior to training should units within the same trust be 
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randomised to receive training during different phases. This would have made 
data analysis difficult. Another major difficulty would have been selecting the 
level at which randomisation should take place. Ideally, this should be at the 
level of the colonoscopist in order to provide groups with similar baseline 
characteristics such as experience and baseline ADR. This is likely to have 
resulted in some colonoscopists within a unit receiving the intervention whilst 
others were not. Maintaining blinding of the control group and the quality of 
study promotion in this setting would have been very challenging as it would 
have required endoscopy nurses to differentiate colonoscopists that were in 
the intervention group from the controls and also for the study posters to be 
removed and replaced between lists. The increased complexity of this 
methodological type is likely to have limited enthusiasm for the study. 
Controlling at the level of the unit would have been logistically simpler, 
however, would present other problems such as the heterogeneity of 
colonoscopist‟s performance, variable uptake and differing number of 
procedures that each would contribute to the total, a difficulty we faced even 
with our more simple study design. This could result in the difference between 
the intervention and control groups being inconsistent. This would also have 
been difficult to estimate as our most robust marker of compliance (change in 
BR) is a surrogate, and does not provide us with information regarding use of 
the other components of the bundle. 
 
When analysing any dataset, it is important to consider whether any changes 
observed could be as result of regression (or reversion) to the mean. Sir 
Francis Galton described this phenomenon in 1885 when studying, among 
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other areas, the relationships between parents and their children‟s heights. 
(85)  He found that parents that were either very tall or very short tended to 
have children that were shorter or taller than them respectively. He proposed 
that the reason for these findings were that, as the parents‟ heights were at 
the extremes of a normal distribution, their children were statistically more 
likely to attain a height closer to the population mean.  If we were to apply this 
concept to our dataset, we would expect the ADRs of those in the upper and 
lower quartiles to fall and improve respectively. We do see this effect within 
our dataset for quartiles, albeit the effect is not as dramatic as it may seem in 
the cumulative data when analysed using funnel plots. If we examine the 
results of the upper middle quartile, the baseline ADR of 17.5% is above the 
mean and might be expected to fall if reversion to the mean was the 
explanation for all results observed. It does, however, climb to 19.2%. Whilst 
this result is non-significant, it does add some weight to the argument that the 
study intervention did influence the changes in ADR observed albeit we 
cannot completely exclude regression to the mean as a contributing factor. 
 
Changes in behaviour and improvement in performance can be seen when 
individuals are aware they are being more closely observed than usual. The 
term “the Hawthorne effect” is often used when describing this phenomenon. 
(86) It was first observed in the 1920-30‟s in a study of productivity performed 
at the Hawthorne Works, which produced electrical equipment, in the US state 
of Illinois. In this study, it was assumed that providing more light to the 
workers would improve productivity, however, it was found that productivity 
improved both in groups provided with more light and those that worked under 
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more limited lighting. Mayo, a member of the research team, felt that the input 
from the additional attention on workers afforded by the study team was the 
factor that had influenced behaviour. Since this description, others have 
attempted to refute the theory offering other explanations for the changes 
observed such as the feedback received by the workers on productivity that 
were not previously provided. 
 
Despite the debate surrounding the Hawthorne effect, the term has been 
extended to other areas including medical research. McCarney et al 
demonstrated the effect in their RCT of Ginkgo biloba in the treatment of mild 
to moderate dementia. (87) Participants were also randomised to receive 
either intensive or minimal follow up. It was demonstrated that those in the 
intensive follow up arm had a significantly better cognitive function scores. 
Other studies have found less of an effect including that performed by Fernald 
et al in their quality improvement study on the management of skin and soft 
tissue infections (SSTIs) by family practitioners. (88) They found that the 
intensity of the intervention, in terms of amount of contact with the research 
team, had no significant effect on management of SSTIs.  
 
Another potential influence on behaviour, as reported in our qualitative work in 
the previous chapter, is knowledge of peer performance. (84) This method of 
engagement was deliberately utilised during the feedback sessions in which 
preliminary data were presented including performance from other units. This 
appeared to have the desired effect as reported in the qualitative work. It is 
possible that presenting performance data from other units participating in the 
 160 
 
study during the initial local training sessions may have increased uptake from 
the outset of the study. Unfortunately these data were not available during this 
study, however, this should be given serious consideration to aid uptake in 
future work.  
 
The feedback provided in this study was anonymised and kept at unit level. It 
had been discussed whether we should provide colonsocopist and even 
named performance data. The study team felt anonymised, unit level was the 
most appropriate in the context of a study in which uptake was key as 
providing named data had the potential to antagonise and potentially lead to 
disengagement.  
 
The use of performance tables in quality assurance and improvement is an 
interesting concept and one that does require further work through carefully 
designed studies that will allow the effect of such tables to be distinguished 
from other contributing factors. The use of performance tables, of course, is 
not without challenges. Firstly, it is important to present and interpret 
performance data appropriately. The potential problem of interpreting 
performance data from units performing variable procedure numbers is 
discussed in Chapter 2. Whilst the use of funnel plots helps adjust for this it 
does not take into account other variables. (89) Adjusting for all variables can 
be challenging as can separating factors intrinsic to an individuals or unit from 
extrinsic factors regarding which an organization may have little control. Other 
potential issues include the risk of gaming results to achieve targets both at 
the level of the colonoscopist and organization and over emphasis on 
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quantitative targets in order to avoid penalties including inappropriately 
stopping individuals performing colonoscopy rather than re-assessing or 
providing additional training. (90) Despite the above, the use of comparative 
results can be useful but must be used with care and sensitivity. 
 
The study design options available within the time and resource constraints of 
this project were considered in detail and it was felt that our method of 
performing a pragmatic study using a simple before and after design for a 
designated period of time was the most likely to succeed. The implementation 
method was feasible and any clinical benefit could be measured relatively 
easily. We cannot completely exclude reversion to the mean or the Hawthorne 
effect having some influence on the results nor the contribution from 
feedback, an intentional component of the intervention to improve 
engagement. Therefore, the change in behaviour observed in this study is 
likely to have been as a result of the study intervention with a possible 
contribution from outside factors including the Hawthorne effect and 
regression to the mean. 
 
7.2.2. Study Power 
The limitation of the study imposed by low procedure numbers has been 
previously mentioned. This becomes a particular issue when analysing data at 
the level of the individual colonoscopist. When considering change in BR, this 
is less of a problem as the changes in question were mostly large and so a 
statistically significant increase in BR could still be demonstrated. Despite this 
it is still possible to have missed individuals who did significantly increase their 
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BR but to a smaller degree. Had we stated that a minimum number of 
colonoscopies needed to be performed by each colonoscopist for inclusion in 
the study, we would have had to either exclude a large number of 
colonoscopists, or alternatively run the study for an extended period of time.  
 
Of the options above, the first would have been unhelpful in this type of work 
as service improvement projects must be maximally inclusive. Furthermore, 
there is some evidence to suggest that colonoscopists performing the fewest 
procedures have poorer quality markers and show the greatest variation in 
practice. (40, 91, 92) Therefore, it is this group that could potentially benefit 
most from an intervention such as the one in this study. Running the study 
over a prolonged period of time may have been possible but would have 
risked decreased compliance over time. Whilst this would have provided 
interesting data with regard to durability of the intervention, it would also have 
limited evaluation of its efficacy. It may have also have been logistically 
difficult to carry out with the resources available.  
 
The study was also underpowered to detect a change at the level of the 
hospital unit. Using a traditional sample size calculation at the level of the unit 
is overly simplistic. It considers the endoscopy unit as the smallest unit of 
measurement whereas the unit is made up of individual colonoscopists. Each 
colonoscopist will also contribute a different number of colonoscopies to the 
unit total. Furthermore, the heterogeneity in baseline performance within units 
dictates each colonoscopist has a different potential to improve. Lastly, it 
assumes a high level of compliance with all components of the „bundle‟ and 
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that this will be uniform amongst the participating units. The colonoscopists 
themselves may also demonstrate varying compliance to different 
components of the bundle and may have been using them routinely prior to 
the intervention, accurate data on which was unavailable with the exception of 
Buscopan use. The same issues arise when considering power calculations at 
a global level if not more so.  
 
In summary, when considering the many variables that exist, power 
calculations to detect small changes in clinical outcomes can be problematic 
in service improvement work. Selecting an appropriate end point in service 
improvement work is discussed further below. 
 
7.2.3. Data collection 
The data collection for the study was performed by interrogating the 
endoscopy reporting software at each unit and so can be considered to be 
retrospective. This is not ideal as it relies heavily on accurate documentation 
from the endoscopist entering the report. The quality of report writing was also 
variable, as has been previously reported in the published literature. (34)  As 
a result, other data that would potentially have been of interest, such as total 
number of polyps and adenomas and polyp morphology, could not be 
collected. The latter may have been of particular value given the greater 
variability in detecting flat lesions although the study was not powered to 
detect changes at polyp level. (79) The ideal approach would have been to 
data collection would have to gather it contemporaneously, however, 
resources dictated that this was not feasible. Furthermore, such an approach 
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would have had the potential to further influence colonoscopist behaviour 
(Hawthorne effect), requiring a member of the research team to be present in 
the endoscopy room to enable accurate data collection. I certainly 
acknowledge that evaluation of factors effecting detection of polyps of 
differing morphologies would be useful and should be studied in future work. 
 
7.3. End-points in service improvement studies: predicting future 
improvements 
The end-point of clinical studies has traditionally been given at the level of 
patient outcome. This may not be appropriate, however, for service 
improvement studies. The primary reason for this is that, whilst the selected 
intervention may be important, outcomes at the patient or individual level may 
be small or infrequent requiring large numbers to demonstrate significance, as 
discussed above. In order to help select appropriate end-points, Lilford et al 
proposed a model based on the Donabedian causal chain of structure, 
process and outcome and is shown in  
Figure 29. (93) 
 
Figure 29: Modified Donabedian causal chain (used with permission of the 
British Medical Journal). 
 
 165 
 
 
This model is based on the concept that interventions to the left of the chain 
will have effects further downstream. Therefore, if the intervention X is 
implemented, it will affect clinical processes and subsequently patient 
outcomes. Certain interventions may also have upstream effects, such as the 
implementation of a new set of guidelines in one area encouraging reference 
to guidelines in other areas, thereby improving these services. Using this 
model, if there is a clear relationship between a process and outcome but the 
outcome measure is small, it may be reasonable to assume that a measurable 
change at the process level will result in a significant change in outcome over 
time.  
 
The converse may also be true depending on the respective process and 
outcome to be investigated. A good example would be the study performed by 
Pronovost et al and discussed in chapter three. (64) In this study, whilst 
compliance with the intervention was recorded locally, the data was not 
analysed or published as this would have taken considerable resource. 
Instead, the outcome, which was expected to be large based on the results of 
prior studies, was indeed so and measurement of this was much simpler and 
yielded results that were within the realms of expectation. A potential flaw in 
not analysing the data on uptake of the intervention at the process level is that 
cause and effect is more difficult to prove and may have been the result of 
other processes underway in the same organisation. In this particular study, 
however, this was not the case to the best knowledge of the study team. 
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When considering the QIC study, it is certainly feasible that encouraging best 
practice will, in the longer term, yield positive results by way of increased ADR 
at the level of the colonoscopist. Therefore, as we have demonstrated 
change, evidenced by change in BR, it is reasonable to assume that we will 
see an increase in ADR among colonoscopists that took up the intervention 
when sufficient procedure numbers can be included. This is supported by the 
results we observed at the quartile level and globally. This, again, highlights 
the importance of the continuous process required in service improvement 
work. 
 
7.4. Evidence to support use of the „bundle‟ measures 
The use of a minimum withdrawal time of 6 minutes is supported by high 
quality evidence and is recommended by national guidelines. However, the 
remaining measures within the „bundle‟ utilised in this study are supported by 
varying degrees of evidence and, therefore, their individual contribution to 
increased adenoma detection is less predictable. Following the completion of 
this study, further data have been published that we must consider. 
 
Yoong et al perform a randomised double-blind controlled trial evaluating the 
effect of Buscopan on CIR and speed of completion published in 2004. (94) 
They found no significant difference in either CIR of completion time.A survey 
of Buscopan use and whether concurrent glaucoma effected use was 
performed by Bedford et al. (95) This survey of BSG and Association of 
Coloproctology of Great Britain and Ireland member revealed that 85.6% 
(123/183) of respondents sometimes or always use Buscopan, 77.4% 
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(137/177) always enquire about glaucoma history and 70.8% (126/187) with-
hold the drug if glaucoma of any kind is reported. The self reported use of 
Buscopan was much higher than observed in our study possibly due to a 
degree of selection bias among respondents.  
 
There have also been three randomised, double blind, placebo controlled 
trials evaluating the use of Buscopan on polyp and adenoma detection that 
have yielded conflicting results. Corte et al reported a significant increase in 
the total number of polyps detected per patient in the Buscopan group. The 
PDR and ADR was also higher in the Buscopan group but did not reach 
statistical significance. (96) The other two studies revealed no significant 
difference between the Buscopan and placebo groups. (97, 98) A potential 
limitation was the fact that the ADRs in the placebo group of all the studies 
were high ranging from 21.8% to 30.0%. The findings of our study suggest 
that this group are less likely to improve and so one may have been predicted 
that the addition of Buscopan was less likely to have made a significant 
difference when compared to colonoscopist sub-groups with a lower ADR. 
Further work evaluating the benefit of Buscopan among colonoscopists whose 
ADR is below average would be of interest. 
 
The data surrounding the additional lesion yield provided by rectal retroflexion 
are also variable and likely to be relatively small. In addition to the study by 
Hanson et al discussed in Chapter 3, further studies by Tellez-Avila et al and 
Saad et al revealed a non-significant increase in lesion detection using 
retroflexion compared with examination in the forward view. (99, 100) Tellez-
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Avila, however, still recommended its use in light of the low associated risks 
whereas Saad suggested it should remain at the discretion of the 
colonoscopist. Based on the evidence available I would suggest that 
continued training in retroflexion is essential but would accept that its use 
should be left to the colonoscopist. Its safety when used appropriately means 
that it should be strongly consider in the majority of procedures, particularly in 
the older age group. 
 
The data regarding the use of dynamic position change is limited. In addition 
to the study by East et al discussed in chapter 3, two further studies have 
been published by Koksal at al and more recently Ou et al. In their study of 
102 patients, Koksal et al found that the use of position change, as described 
in chapter 3, resulted in a significant increase in ADR, a significant increase in 
the number of adenomas detected in the transverse and sigmoid colon and 
also an resulted in the a shortening of the colonoscopy surveillance intervals 
in 8.8%. (101) The study performed Ou et al included 776 patients and 
revealed no difference in PDR or ADR with position change. (102) Despite the 
conflicting results as to the benefit of this measure, given its simplicity and 
safety, I would recommend its routine use. 
 
The rationale for using a „bundle‟ of measures rather than a single change 
was that, whilst the effect of each in isolation may be small, their use in 
combination may yield a significant increase in ADR, that, in light of the work 
of Corley et al is worth striving for. Furthermore, each is simple, safe and both 
cost and time efficient and can be performed by all colonoscopists in all 
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endoscopy units. Also, the results of this study, accepting its limitations, 
suggest that they may be useful especially for colonoscopists whose ADR is 
below average and we would continue to recommend their use particularly in 
this subgroup. Further work is required to confirm the findings of this study as 
discussed below.  
 
In summary, the results of this study confirm that change in clinical practice 
can be successfully achieved using a multi-faceted educational intervention.  
The changes in ADR indicate that colonoscopists with below average ADR 
may see the greatest benefit. The Donabedian model also suggests that by 
encouraging best practice, it is reasonable to expect an improvement in the 
future at the level of the individual colonoscopist and a more significant 
increase in ADR may be seen in time. The reasons for the changes in ADR 
observed are likely to be multi-factorial including those intrinsic to the study 
intervention („bundle‟ measures, feedback, awareness of peer performance, 
increased awareness of quality measures and indicators) and possible 
contributions from unintended factors (the Hawthorne effect and regression to 
the mean) all of which are important to appreciate if similar initiatives are to be 
conducted in the future. 
 
7.5. Key findings from the QIC study 
 This study demonstrates clearly that unacceptable variation in ADR does 
exist despite acceptable CIRs. 
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 The pre-intervention ADR funnel plots demonstrate that the current 
recommended national standard is too low and should now be reviewed in 
the light of this work and that of others. Serious consideration should be 
given to resetting the standard to be achieved at 15% initially, with aim of 
raising it further in the not too distant future. 
 
 The model of implementation used in the study resulted in successful 
integration of evidence into routine clinical practice. 
 
 The study intervention led to an improvement in the ADR, particularly for 
colonoscopists who were below average for this key performance 
indicator. Variation was reduced although not completely eliminated.  
 
 Good local study promotion and feedback were important components of 
the implementation model. 
 
 Factors influencing the observed results are multiple including those 
intrinsic to the study intervention and unintended factors (the Hawthorne 
effect and regression to the mean). 
 
 Consideration should be given for similar future projects to encourage 
participation among groups predicted to engage poorly at the outset. 
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7.6. Further work 
Service improvement work, as discussed above, must be a continuous 
process. Questions raised in the analyses of the current study highlight 
several areas for further work. 
 
Durability 
A follow up study to evaluate whether performance and uptake of the bundle 
were maintained would be of great value. 
 
The Implementation Model 
The qualitative evaluation confirmed that there were several components of 
the implementation model that influenced uptake of „bundle‟ such as 
endoscopy nurse involvement and feedback. Given that quality improvement 
projects often have limited resources, it would be useful to understand which 
components had the greatest influence. For example, if it were to be 
demonstrated that feedback or knowledge of peer performance (bench 
marking) played the greatest role, this would be of significant use when 
designing future models. Such a project would be a complex undertaking 
could result in a significant cost saving in future implementation programmes. 
 
Reproducibility 
It is now enormously important to understand if the changes in practice seen 
in the QIC study could be replicated using the same implementation model in 
endoscopy units outside of NREG. 
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There is a need to evaluate whether a similar degree of change been 
demonstrated using a similar implementation model in other clinical care 
settings. 
 
Clinical Outcome 
It would be important to confirm whether the changes in ADR observed were 
as a result of use of the intervention. This would require a randomised 
controlled trial, which would also be a challenge to undertake, but would 
provide an answer to the question. The effect on total number of adenomas 
detected and polyp of differing morphologies could also be evaluated. 
 
7.7. Overall Summary 
The QIC study was a large scale service improvement study using evidence 
based methodology with the aim of improving ADR of participating 
colonoscopists by implementing evidence based measures into routine 
colonoscopy practice. The results demonstrated that a multi-faceted 
implementation model brought about a significant change in practice. This 
resulted in a global increase in ADR and more importantly an improvement in 
the poorest performance, reducing in the variation observed at the outset of 
the study. The reasons for the changes observed are multi-factorial including 
the components of the intervention and outside factors. The value of an 
inclusive approach to study promotion and feedback were highlighted together 
with the importance of developing methods to engage groups predicted to 
resist change. The questions raised by the results have provided impetus for 
further work the early development of which is underway. 
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7.8. Summary of publications and presentations 
Below is a summary of the work published and presented as a result of this 
project. 
Full Publications 
 A multicenter pragmatic study of an evidence-based intervention to 
improve adenoma detection: the Quality Improvement in Colonoscopy 
(QIC) study. Endoscopy, 2015. (In Press) (103) 
 Achieving high quality in colonoscopy: using graphical representation 
to measure standards and reset standards. Colorectal Diseases, 2012. 
(104) 
 
Published Abstracts 
 A multi-centre pragmatic study of an educational intervention to 
improve adenoma detection at colonoscopy. Oral presentations at 
United European Gastroenterology Week (Awarded an oral free paper 
prize), 2013 and the British Society of Gastroenterology Annual Meeting, 
2014 and poster presentation at Digestive Diseases Week, 2014. (105-
107) 
 The Challenges of Implementing Evidence into Practice: A Qualitative 
Study. Poster presentations at the British Society of Gastroenterology, 
2013, United European Gastroenterology Week, 2013 and Digestive 
Diseases Weeks, 2014. (108, 109) 
  Using a „conversion factor‟ to estimate adenoma detection rate. 
Poster presentation at the Digestive Disorders Federation, 2012 and 
United European Gastroenterology Week, 2012.(110) 
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Appendix A 
Data Collection Form 
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Appendix B 
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Appendix C 
QIC Training Day Minutes 
Introduction by MR 
 Aims of QIC (intervention bundle to improve ADR – surrogate 
marker of quality) 
 Designed as a service improvement study 
 Potential problems highlighted – how to influence people/get people 
to “buy in” 
Overview of QIC including evidence base (by JE)(Appendix C) 
 Overview presented. 
 ADR as a marker of quality in colonoscopy (Kaminski et al). 
 Why use ADR – most closely associated with interval cancer rate 
 Varying standards worldwide – GRS 10%/BCSP 35%/US 15-25% 
 Standards vary greatly (Barclay et al) 
 Factors effecting ADR discussed (Rex et al) 
 Reasons why increasing ADR important i.e. future cancer risk 
 Factors that influence future improvement – simple feedback of poor 
performance appears not to. 
 Example of an “intervention bundle” implemented in ITU to reduce line 
sepsis presented 
 Components of intervention bundle in QIC discussed. 
o Time – increased time = increased ADR (Barclay et al) 
o Buscopan 
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 old data and whilst used in CT colonography 
demonstrating increased PDR when used in those with 
visible spasm. 
 Variation in use 
 Must be used in caecum at latest but can be used sooner 
 Glucagon is an alternative when contraindicated 
 Probably can use in glaucoma if used drops (? Liaise with 
ophthalmology) 
o Position change –left lateral for right colon, supine for transverse 
and right lateral for left colon – supine and right lateral have 
largest influence. 
o Rectal retroflexion – small effect. 
 Time line discussed including when implementation of bundle planned 
and subsequent data gathering points. 
 Summary 
 
NREG and QIC (by CJR) (Appendix C) 
 About NREG including past and current projects 
 Importance of academic detailing 
o Outline today 
o How “leaders” train their units 
o How were those who didn‟t agree persuaded (or not) 
o Nursing influence 
 Incentives 
o Training for those who need it 
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o CPD points 
o External speakers (added influence?) 
 What should we do about right sided lesions? 
o Build into DVD? i.e. use of cold snare techniques 
 Training in rectal retroflexion (also on DVD) 
 How will be audit? 
o PR to get feedback on how the trainers trained (we will provide 
protocols/suggestions on how this was might be done). 
o Need random and single blinded audit (frequency to be decided) 
o Need to document size of lists before/after implementation of 
bundle 
 How quality will be assessed. 
o ADR 
o Interval cancer rate in the future?? 
 
Academic detailing and educating doctors (by MGB) (Appendix C) 
 Discussed all those involved in a colonoscopy that can influence 
outcome/participation – endoscopist/patient/nurse/assistant 
 Trainees can influence unit culture change i.e. those who have trained 
in other units. 
 How do we get people to change? 
o Instruct i.e. from high up in the organisation 
o Negotiate (two or more way discussions) 
o Pilot study 
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o Persuade – audit/research/benchmark 
o Educate 
 What factors influence change in behaviour? 
o Willingness i.e. possible resistance from the very experienced 
endoscopist 
o Influence of the leader/enthusiast 
o Hearing objections +/- persuade  
o Sanctions for non-compliance 
o Peer pressure 
 What are the incentives? 
o Improved quality for patients. 
o Improved quality/performance of the unit 
 How do we ensure limit on list length (i.e. stick to 12 points)?  
o Role of leaders/nurses in this 
 When is data fed back? 
o What about monthly scores? 
 Regarding QIC things we need to do are: 
o Decide strategy 
o Decide methods 
o Quick ??? 
o Get nurses on board 
o Listen to colleagues 
o Audit 
o Support units and feedback 
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Questions and comments  
 How will the indication for colonoscopy effect ADR? (SP). Answer: We 
need to try and record indication as this will need to be analysed. 
 Will the BCSP limit the potential to improve ADR i.e. less polyps out 
there? (AD). Answer: Difficult to say. 
 Bringing about change will be difficult. Nursing staff pressure will be 
important. (MB) 
 Does time include time for polypectomy? (JP). Answer: No. Normal 
scopes only. 
 How do we ensure uniform withdrawal? (JP) Should we consider 2 
minutes from caecum to hepatic, hepatic to splenic, splenic to sigmoid, 
sigmoid to rectal retroflexion with photographic evidence at each point? 
Should we use a bell as a reminder of time? Answer: Probably too time 
consuming and not all centres have reliable access to photo capture. 
 How robust is the evidence? How will we convince endoscopists that 
increasing from 6 to 8 minutes worth while? Vote taken and decision 
use 6 minutes.  
 Enthusiasts more likely to engage than non-enthusiasts. How do we 
convince surgeons?  
o Suggestion: 1) Surgeons to talk to surgeons (surgical buddy). 2) 
Medical director support. 3) Competition (i.e. monthly/bimonthly 
ADR tables) 4) Outside speaker. 
 How will increased time affect length of lists? Will lists end up being 
cut? Answer: Need to monitor this as my affect enthusiasm and 
pressure from management. 
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 Poster in each room will help with compliance. 
Overall (after ideas debated and votes taken) 
 The “Bundle” 
1. Colonoscopy withdrawal time = 6 minutes (no bell) 
2. Routine use of Buscopan (or glucagon if contra-indicated) 
3. Supine position for examination of transverse colon 
4. Routine retroflexion in the rectum 
 Training to be delivered by research fellow for consistency. 
 Training sessions should be a maximum of 45 minutes. 
 Engage endoscopy nurses to promote study. 
 Compliance assessments to be performed by nursing staff. 
 Posters for all rooms. 
 
 
 
 
 
 
 
 
 
 
 
 199 
 
Appendix D 
The Quality Improvement in Colonoscopy 
(QIC) Study
on behalf of the Northern Region Endoscopy Group (NREG)
Remember to ROUTINELY
1. Give buscopan on reaching the caecum if  
not before
2. Take at least 6 minutes to withdraw
3. Use supine to examine transverse colon 
4. Retroflex in rectum
Thank You !
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Appendix E 
Quality Improvement 
in Colonoscopy (QIC) 
Study
 
Colorectal Cancer
 Common problem in the UK.
 3rd most common cancer and 2nd most common 
cause of cancer death (approx. 16,000 per year)
 Most detected when symptomatic.
 NHS BCSP commenced roll-out in 2006 
 In addition to earlier stage cancers a high number of 
adenomas were detected
 The majority of colonoscopies are done outside 
of the BCSP – offers an opportunity to detect 
and remove adenomas potentially reducing the 
incidence of colorectal cancer.
 
Background
 Colonoscopy is the criterion standard for 
dysplasia detection and therapy
 High quality colonoscopy is fundamental to 
National Bowel Cancer Screening Programmes 
(BCSP) 
 We should also strive for high quality in 
diagnostic services.
 Recent emphasis on colonoscopic quality via 
GRS
 Polyp / adenoma detection rates
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Current Benchmarks/Standards
 Joint Advisory Group (JAG)/ GRS
 10% adenoma detection rate
• Advanced adenomas
• >2 adenomas
 United Kingdom BCSP
 FOBT +ve: 35% adenoma detection rate 
 US Multi-society guidelines
 1st screening colonoscopy aged ≥ 50Y
• ADR: >15% female, >25% male patients
 
Does adenoma detection matter?
 Adenomas matter (even small ones!!).
 Patients undergoing surveillance colonoscopy 
following baseline colonoscopy were evaluated and 
relative risks for advanced neoplasia calculated.
 Those with ≥3 small adenomas (10mm) at baseline 
had a RR 5.0 (95%CI 2.1-12.0) for advanced 
neoplasia at 3-5 years1.
 Current British Society of Gastroenterology 
(BSG)  recommends that those with 3-4 
adenomas < 1cm undergo surveillance 
colonoscopy at 3 years.
1Lieberman DA et al. Gastroenterology 2007;133:1077-1085
 
Does Adenoma Detection Rate 
matter?
 ADR is associated with interval cancer1
 ADR <20% had hazard ratio for interval cancer of 10 
times that of ADR > 20%.
 ADR is a marker of 
quality in colonoscopy 
and a lower ADR 
is associated with an 
increased risk of interval
cancer.
 1Kaminski MF et al. N Engl J Med 2010;362:1795-1803
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Summary
Colorectal cancer is an important problem.
 Potentially preventable by high quality 
colonoscopy which detects and removes 
pre-malignant colorectal adenomas.
 The presence of colorectal adenomas is 
associated with future cancer risk.
Colonoscopist‟s ADR is linked to interval 
cancer and therefore is a marker of quality 
in colonoscopy. 
 
The problem is......
 Variability in adenoma detection (therefore 
quality). 
1. 10-fold variation for adenomas all sizes1
• 0.1-1.05 adenomas per patient
2. 3-4 fold for adenomas ≥10mm2
3. Cancer miss rates3
• 3.0% vs 5.6% missed/new within 3 years of 
colonoscopy
4. Failure to prevent right sided cancers4
1 Barclay R et al. N Engl J Med 2006; 355:2533-2541
2 Chen SC et al. Am J Gastroenterol 2007;102:856-61
3 Bressler B et al. Gastroenterology 2007;132:96-102
4 Baxter N et al. Ann Intern Med 2009;150:1-8
 
Adenoma miss rates
 van Rijn JC et al. Am J Gastroenterol 2006;101:343-50
Meta-analysis of six studies involving same day 
colonoscopies x2.
Pooled (for all polyps) = 22%
Adenomas > 10 mm = 2.1%
Adenomas 5-10 mm = 13%
Adenomas1-5 mm = 26%
 
 
 203 
 
Operator performance as a 
factor in miss rate
Withdrawal times1
 r=0.76
 p<0.0001
 48% miss rate vs 17% miss rate2
1. adequacy of time spent viewing
2. cleaning and suctioning
3. examining the proximal sides of flexures, folds and valves
4. adequacy of distension
1Simmons DT et al. Aliment Pharmacol Ther 2006;24:965-71
2Rex DK. Gastrointest Endosc 2000;51:33-36
 
Summary
Wide variation in adenoma detection rates
 Adenoma detection rates important
Operator performance is a (major) factor
 
Concept
 Collaborative cohort study
 “Before and after” design - service 
development
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Intervention
 108 ICUs: 5 evidence based procedures
1. Hand washing
2. Full barrier precautions
3. Chlorhexidine skin cleaning
4. Avoiding femoral site
5. Removing unnecessary catheters
 Team leaders
 Instructed in science of safety & interventions
• Coaching, teleconference, state-wide meets 6/12
• Info on efficacy, implementation suggestions
• Leaders disseminated the information back to their 
units.
 18 months follow up, 1981 ICU months
 
Baseline
 
Concept summary
Collaborative cohort design
 Implementing “bundle” of best evidence
 Local team leadership with support
 Efficacy and durable outcomes
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QIC Study Design
 Collaborative cohort design
 “Before and after” observations
 Use NREG as a network 
 Introduce a „bundle‟ of evidence based measures 
 Educational package
 Supported team leaders and study team
 Measureable improvement in colonoscopy quality in 
multiple endoscopy units
 Number of patients with ≥1 polyp recorded
 Adenoma detection rates
 
Evidence based interventions
1. Minimum withdrawal time of 6 minutes.
2. Routine antispasmodic use - buscopan
20mg IV
3. Position change 
 Specifically supine position for examination 
of transverse colon
4. Routine rectal retroflexion
 
Minimum withdrawal time (1)
1Barclay R et al. 
N Engl J Med 2006; 355:2533-2541
 2053 screening colonoscopies studied.
Association between   adenoma 
detection and both mean total withdrawal 
time and mean withdrawal time  (MWT) of 
normal colonoscopies evaluated.
Longer  withdrawal time is associated 
with higher adenoma detection.
All lesions
MWT < 6min = 11.8%
MWT > 6min = 28.3%
Statistically significant (p <0.001)
Advanced lesions
MWT < 6min = 2.16%
MWT > 6 min = 6.4% 
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Minimum Withdrawal time (2)
“In all models, only mean procedure time was associated with polyp 
detection rates”
Imperiale TF et al. Gastrointest Endosc 2009;69:1296-8
1. Simmons DT et al. Aliment Pharmacol Ther 2006;24:965-71
 Study designed to find optimal 
colonoscopy withdrawal time for 
maximal lesion detection.
 10,995 colonoscopies analysed
 PDR correlated with withdrawal 
time
 Median PDR = 42.7% found to 
be at 6.7 min
 Variation on PDR decreased 
within increasing polyp size.
 
Minimum withdrawal time (3)
Barclay R et al. Clin Gastroenterol Hepatol 2008;6:1091-8
Sawhney M et al. Gastroenterology 2008;135:1892-8
 
Antispasmodic
 Antispasmodics are used by 20% UK colonoscopists1
 Hyoscine N-butylbromide (Buscopan)
 Glucagon
 Potentially flatten haustral folds revealing more colonic 
mucosa
 Reduce peristaltic waves and spasm
 No improved polyp detection with glucacon2
1Bowles CJ et al. Gut 2004;53:277-83
2Cutler CS et al. Gastrointest Endosc 1995;42:346-50
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Antispasmodic
East JE et al. Gut 2009;58 (Suppl 1);A122
 
Antispasmodic
 Randomised study (n=116)1
 Spasm score was reduced with Buscopan
 Improved polyp detection in those with severe spasm
• 1.2 versus 0.4, p=0.06
 Expert opinion favour antispasmodics for difficult to 
detect lesions2
1Lee JM et al. Hepatogastroenterology 2010;57:90-4
2Kiesslich R et al. Gut 2004;53:165-76
 
Dynamic position changes (1)
 14 patients had back to back 
colonoscopies video taped.
 One solely in left lateral position 
and then with position changes.
 Videos reviewed by blinded 
reviewer and luminal distension 
scored.
 42% of patient examined in left 
lateral alone had diagnostically 
unacceptable distension scores
East JE et al. Gastrointest Endosc 2007;65:263-69
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Dynamic position changes (2)
 130 patients underwent back to back 
colonoscopy – one left lat. only and one 
with dynamic position change.
Outcome measure were polyp/adenoma 
detection rate and luminal distension 
scores.
1. East JE et al. Gastrointest Endosc. 2010 (In Press)
 
Dynamic position changes (3)
 East JE et al. Gastrointest Endosc 2010 (In press)
 
Dynamic position changes (4)
 Luminal distension improved with 
dynamic position change1
 Adenoma detection improved with 
better luminal distension 
(p<0.001)2
 Luminal distension correlates with 
adenoma detection r=0.12
1. East JE et al. Gastrointest Endosc. 2007;65:263-69
2. East JE et al. Gastrointest Endosc. 2010 (In Press)
5 or 4
3 or 2
1
16%
7%
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Rectal retroflexion
 Flexiscope trial (480 patients)1
 12 (2.5%) polyps seen only on retroflexion
• 4 (1%) adenomas (3 TAs <5mm, 1 x 15mm TVA)
 Large colonoscopy series (1502 cases)2
 40 (2.7%) had a distal rectal polyp
 8 polyps seen in retroflexed view only
• 1 x 4mm tubular adenoma
1Hanson J et al. Dis Colon Rectum 2001;44:1706-82
2Saad A et al. World J Gastroenterol 2008;14:6503-5
 
Evidence based „bundle‟ of 
changes
1. Minimal withdrawal time (> 6mins)
 In all cases (intact colon)
2. Antispasmodics (buscopan 20mg IV)
 Should be given at caecum at latest in all cases 
unless contraindicated
3. Position change
 Minimum of supine for transverse colon
4. Rectal retroflexion
 All cases unless contraindicated
 
Outcome measures
1. Uptake of the intervention 
„bundle‟
2. Change in polyp/adenoma 
detection rate
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Timeline
-3 0 3 6 9 12
Baseline data 
collection
Intervention
Efficacy endpoint Durability end point
Ongoing supportOct 2010 Jan 2011 Dec 2011
 
Central Training Day
 All lead endoscopists and lead endoscopy 
nurses attended training day 16/9/10.
 Principles of study outlined.
 Potential local implementation problems 
discussed.
 Solutions agreed.
 Study design refined in light of above. 
 Letters sent to all medical directors to acquire 
support for QIC.
 
What data will we record?
 Unit
 Month
 Colonoscopist (anonymized)
 Time of list (AM/PM)
 Mean list length (points)
 Mean age of patient
 Sex distribution (percentage 
M/F)
 Indication for colonoscopy
 Mean sedation/analgesia dose
 Buscopan use
 Mean bowel prep score
 Mean comfort score
 Polyp detection rate
 Polyp retrieval rate
 Polyp size???
 Adenoma detection rate
 Complications
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Recording your data
 Please record all polyps detected using 
the drop down menus where possible -
makes collecting polyp/adenoma detection 
rate data much easier.
 Please record if polyps are retrieved.
 Please record size of polyps (??should we 
record this)
 Please include bowel preparation scores 
in your colonoscopy report,
 
Compliance assessments
Will be performed by endoscopy nursing 
staff using a 4 point score
Will include 30 normal colonoscopies.
Will occur once in initial 3 months 
(efficacy) and twice during subsequent 9 
months (durability).
Will be blinded (“Hawthorn effect”).
 
What happens next?
 Please implement changes from your next 
colonoscopy list – all lists except bowel cancer 
screening lists (excluded).
 Blinded compliance audit at 3, 6 and 12 months.
Please record data as fully 
as possible.
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Summary
 Problem
 Wide variation in polyp and adenoma detection rates
 Due to operators factors
 Adenoma detection rate is a marker of quality in colonoscopy
 Concept
 Pronovost NEJM educational intervention to reduce infection
 Evidence
 “Bundle” of 4 evidence based measures
 Design
 Before and after collaborative cohort study
 Intervention championed by local “team leaders”
 
QIC study
We thank you for your help and 
enthusiasm!!
Any questions?
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Appendix F 
The Quality Improvement in 
Colonoscopy (QIC) Study
 
Colorectal Cancer (CRC)
 Common problem in the UK.
 3rd most common cancer and 2nd most common 
cause of cancer death.
 Most detected when symptomatic.
 NHS BCSP commenced roll-out in 2006 
 Most colonoscopies are done outside of BCSP
 Great opportunity to detect and remove 
adenomas 
 Potentially reducing the incidence of colorectal 
cancer.
 
Background
 Colonoscopy is the criterion standard for 
dysplasia detection and therapy
 High quality colonoscopy is fundamental to 
National Bowel Cancer Screening Programmes 
(BCSP) 
 Need to strive for high quality in diagnostic 
services.
 Recent emphasis on colonoscopic quality via 
GRS
 Polyp / adenoma detection rates
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Current Benchmarks/Standards
 Joint Advisory Group (JAG)/ GRS
 10% adenoma detection rate
 United Kingdom BCSP
 FOBT +ve: 35% adenoma detection rate 
 US Multi-society guidelines
 1st screening colonoscopy aged ≥ 50Y
• ADR: >15% female, >25% male patients
 
Why does adenoma detection 
matter?
 Removal of adenomas reduces incidence of 
CRC1. 
 Small adenomas are associated increased risk 
of future advanced neoplasia.
 Those with ≥3 small adenomas (<10mm) at baseline 
had a RR 5.0 (95%CI 2.1-12.0) for advanced 
neoplasia at 3-5 years2.
 Currently BSG recommends that those with 3-4 
adenomas < 10 mm undergo surveillance 
colonoscopy at 3 years.
1Winawer  et al. N Engl J Med 1993;329:1977-1981
2Lieberman DA et al. Gastroenterology 2007;133:1077-1085
 
Why does adenoma detection 
rate matter?
 ADR <20% had hazard ratio for interval cancer 
of 10 times that of ADR > 20%1.
 A lower ADR is
associated with an 
increased risk of interval
cancer.
 ADR is therefore a
marker of quality in
colonoscopy.
1Kaminski MF et al. N Engl J Med 2010;362:1795-1803
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Summary
 CRC is an important problem.
 Potentially preventable by high quality 
colonoscopy which detects and removes pre-
malignant colorectal adenomas.
 The presence of colorectal adenomas is 
associated with future cancer risk.
 Colonoscopist‟s ADR is linked to interval cancer 
and therefore is a marker of quality in 
colonoscopy. 
 
The problem is......
 Variability in adenoma detection (therefore 
quality). 
 Systematic review of 6 studies involving same 
day colonoscopies x 2 1.
 Pooled (for all polyps) = 22% miss rate.
 Adenomas > 10 mm = 2.1%
 Adenomas 5 -10 mm = 13%
 Adenomas 1-5 mm = 26%
1. van Rijn JC et al. Am J Gastroenterol 2006;101:343-50
 
Operator performance as a 
factor in miss rate
 Withdrawal times1
 r=0.76
 p<0.0001
 48% miss rate vs 17% miss rate2
1. adequacy of time spent viewing
2. cleaning and suctioning
3. examining the proximal sides of flexures, folds and valves
4. adequacy of distension
1Simmons DT et al. Aliment Pharmacol Ther 2006;24:965-71
2Rex DK. Gastrointest Endosc 2000;51:33-36
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Summary
Wide variation in adenoma detection rates
 Adenoma detection rates important
Operator performance is a (major) factor
 
How can we improve things?
 Examination performed during colonoscopy 
withdrawal.
 Will a standard withdrawal technique reduce the 
current variation in adenoma detection?
 Which measures should we incorporate?
The Quality Improvement in Colonoscopy (QIC) 
Study.
 
Concept
 Collaborative cohort study
 “Before and after” design - service 
development
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Concept summary
 Implemented “bundle” of best evidence
1. Hand washing
2. Full barrier precautions
3. Chlorhexidine skin cleaning
4. Avoiding femoral site
5. Removing unnecessary catheters
 Team leaders centrally trained and disseminated 
information to their units.
 Implementation supported by leaders/study 
team.
 Significant reduction in blood-stream infections -
sustained for the follow up period (durability).
 
The QIC Study
 Service development study
 Design
 Collaborative cohort study with “before and after” 
observations using NREG as a network 
 Intervention
 Introduce a „bundle‟ of evidence based measures to 
improve polyp/adenoma detection rate.
 Support from team leaders and study team
 Outcome
 Improvement in colonoscopy quality measured by 
change in PDR/ADR (number of patients with 1 or more 
polyps detected).
 
What is the „bundle‟?
1. Minimum withdrawal time of 6 minutes.
2. Routine antispasmodic (for withdrawal)
 Buscopan 20mg IV or (glucagon 1mg IV if 
buscopan contraindicated)
3. Routine use of supine position for examination 
of transverse colon (during withdrawal)
4. Routine retroflexion in the rectum
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Minimum withdrawal time
1Barclay R et al. 
N Engl J Med 2006; 355:2533-2541
 2053 screening colonoscopies 
performed by 12 colonoscopists.
 Longer  withdrawal time assoc. 
with higher adenoma detection.
 All lesions
MWT < 6min = 11.8%
MWT > 6min = 28.3%
p <0.001
 Advanced lesions
MWT < 6min = 2.16%
MWT > 6 min = 6.4% 
P = 0.005
 
Antispasmodics (1)
 Antispasmodics are used by 20% UK 
colonoscopists - buscopan, glucagon.
 Flatten haustral folds revealing more colonic 
mucosa
 Reduce peristaltic waves and spasm
 
Antispasmodics (2)
East JE et al. Gut 2009;58 (Suppl 1);A122
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Antispasmodics (3)
 Randomised study (n=116)1
 Spasm score was reduced with Buscopan
 Improved polyp detection in those with severe 
spasm
• 1.2 versus 0.4, p=0.06
 Expert opinion favour antispasmodics for difficult 
to detect lesions2
1Lee JM et al. Hepatogastroenterology 2010;57:90-4
2Kiesslich R et al. Gut 2004;53:165-76
 
Dynamic position changes (1)
 14 patients had back to back 
colonoscopies video taped -
one solely in left lateral 
position and then with position 
changes.
 Videos assessed by reviewer 
(blinded) and luminal 
distension scored.
 42% of patient examined in left 
lateral alone had 
diagnostically unacceptable 
distension scores
East JE et al. Gastrointest Endosc 2007;65:263-69
 
Dynamic position changes (2)
 130 patients underwent back to back 
colonoscopy – one left lat. only and one with 
dynamic position change.
 Outcome measure were polyp/adenoma 
detection rate and luminal distension scores.
1. East JE et al. Gastrointest Endosc. 2010 (In Press)
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Dynamic position changes (3)
 East JE et al. Gastrointest Endosc 2010 
 
Dynamic position changes (4)
 Luminal distension improved with 
dynamic position change1
 Adenoma detection improved with 
better luminal distension 
(p<0.001)2
 Luminal distension correlates with 
adenoma detection r=0.12
1. East JE et al. Gastrointest Endosc. 2007;65:263-69
2. East JE et al. Gastrointest Endosc. 2010 (In Press)
5 or 4
3 or 2
1
16%
7%
 
Rectal retroflexion
 Flexiscope trial (480 patients)1
 12 (2.5%) polyps seen only on retroflexion
• 4 (1%) adenomas (3 TAs <5mm, 1 x 15mm TVA)
 Large colonoscopy series (1502 cases)2
 40 (2.7%) had a distal rectal polyp
 8 polyps seen in retroflexed view only
• 1 x 4mm tubular adenoma
1Hanson J et al. Dis Colon Rectum 2001;44:1706-82
2Saad A et al. World J Gastroenterol 2008;14:6503-5
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Evidence based „bundle‟ 
1. Minimal withdrawal time of 6mins
 All cases with an intact colon.
2. Routine antispasmodics (buscopan 20mg IV)
 All cases unless contraindicated when 
glucagon 1mg IV may be used
 Should be given at caecum at latest 
3. Routine use of supine position for transverse 
colon examination (during withdrawal).
4. Routine rectal retroflexion
 All cases unless contraindicated
 
Outcome measures
1. Uptake of the intervention „bundle‟
2. Change in polyp/adenoma detection 
rate
 
Timeline
-3 0 3 6 9 12
Baseline data 
collection
Intervention
Efficacy endpoint Durability end point
Ongoing supportOct 2010 Jan 2011 Dec 2011
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Central Training Day
 12 units participating
 All lead endoscopists and lead endoscopy 
nurses attended training day.
 Principles of study outlined.
 Potential local implementation problems 
discussed.
 Solutions agreed and study design refined. 
 Letters sent to all medical directors to acquire 
support for QIC.
 
What data will we record?
 Unit
 Month
 Colonoscopist (anonymized)
 Time of list ( % AM/PM)
 Mean list length (points)
 Mean age of patient
 Sex distribution (% M/F)
 Indication for colonoscopy
 Mean sedation/analgesia dose
 Buscopan use
 Polyp detection rate
 Polyp retrieval rate
 Adenoma detection 
rate
 Polyp size
 <10mm and 
>10mm
 Complications
 
Recording your data
 Please record all polyps detected using the drop 
down menus where possible - makes collecting 
polyp/adenoma detection rate data much easier.
 Please record if polyps are retrieved.
 Please record polyp size in millimeters
compared to open standard biopsy forceps 
(6mm).
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Compliance assessments
 Will be performed by endoscopy nursing staff 
using a 4 point score.
 Will include 30 normal colonoscopies.
 Will occur once in initial 3 months (efficacy) and 
twice during subsequent 9 months (durability).
 Will be blinded (“Hawthorn effect”).
 
What happens next?
 Please implement changes from your next 
colonoscopy list – bowel cancer screening lists 
excluded.
 Please record data as fully as possible.
 Please complete QIC feedback questionnaire –
you will receive it in a few weeks.
 
The QIC study
 Collaborators
 Durham University
 St. Marks Hospital 
 Funded by an SHA „Good ideas‟ grant.
 Supported by the BSG endoscopy research 
group.
 Department of health have shown support for 
QIC.
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Summary
 Problem
 Wide variation in polyp and adenoma 
detection rates.
 Operators performance is a factor.
 Design
 “Before and after” collaborative cohort study
 Intervention
 “Bundle” of 4 evidence based measures
 Outcome measures
1. Change in PDR/ADR
2. Uptake of “bundle”.
 
QIC study
We thank you for your help and 
enthusiasm!!
Any questions?
 
 
 
 
 
 
 
 
 
 225 
 
QIC STUDY FACT SHEET 
Bottom Line 
1. Polyps and adenoma detection rates are a marker of colonoscopic quality 
endorsed by national societies 
2. Poor quality colonoscopy fails to comprehensively detect polyps and adenomas 
and risks not detecting and preventing colorectal cancer 
3. The following interventions during colonoscopy withdrawal improve polyp and 
adenoma detection:  
 
     A withdrawal time of at least 6 minutes 
     Patient position changes to optimise luminal distension 
     Rectal retroflexion 
     Use of anti-spasmodics 
Current Unit Performance 
Our Unit’s current unit polyp/adenoma detection rate (ADR): XX% 
Recommended ADR for asymptomatic patients age ≥50 years undergoing 
colonoscopy: 20% 
Colonoscopists with an ADR<20% in a large Polish screening colonoscopy study had a 
hazard ratio for interval colorectal cancer that was TEN-TIMES that of colonoscopists 
with an ADR≥20%. 
Kaminski MF, et al. Quality indicators for colonoscopy and the risk of interval cancer. 
N Engl J Med. 2010;362:1795-803. 
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TAKE AT LEAST 6 MINUTES FOR COLONOSCOPE WITHDRAWAL 
Bottom line: Withdrawal time from caecum to anal verge in intact colons should 
take at least 6 minutes 
Observational data from a number of studies has shown that increases in withdrawal 
time are correlated with improvements in adenoma detection. This has led national 
societies in the USA to recommend a minimum colonoscope withdrawal time of six 
minutes. When low detecting colonoscopists who took less than 6 mins to withdraw 
slowed their withdrawal their adenoma detection rate improved. 
Refs: Barclay R et al. N Engl J Med 2006;355:2533-2541, Simmons DT et al. Aliment PharmacolTher 
2006;24:965-71, Barclay R et al. ClinGastroenterolHepatol 2008;6:1091-8 
CHANGE PATIENT POSITION DURING COLONOSCOPE WITHDRAWAL 
Bottom line: Change patient position to supine for examination of transverse colon 
and ideally to right oblique / lateral for splenic-descending to optimise luminal 
distension. 
Examination in left lateral position alone can result in poor views of the transverse 
colon splenic flexure and descending colon, as these lie in a dependant position. 
Changing to supine for the transverse and right lateral for examination of the 
splenic-descending improves luminal distension and adenoma detection. Most of the 
benefit is seen by changing to supine for examination of the transverse colon. 
Refs: East JE et al. GastrointestEndosc 2007;65:263-69, East JE et al. GastrointestEndosc 2010; In Press 
RETROFLEX IN THE RECTUM 
Bottom line: Rectal retroflexion enhances detection of lesions in the distal rectum 
and at the anal verge 
Polyps low in the rectum and at the anal verge are difficult to detect with 
conventional forward viewing instruments. CT colonography studies have shown the 
low rectum is a common site for polyp misses. Rectal retroflexion allows 
comprehensive examination of this area and is recommended by experts. In a study 
of flexible sigmoidoscopy there was a 1% absolute increase in adenoma detection 
with use of rectal retroflexion. 
Refs: Pickhardt PJ et al.  Ann Intern Med. 2004;141:352-9, Hanson J et al. Dis Colon Rectum 2001;44:1706-82 
GIVE ANTI-SPASMODICS BEFORE STARTING WITHDRAWAL 
Bottom line: Antispasmodics reduce peristalsis and smooth muscle tone to give a 
still, flat mucosal surface to aid polyp detection 
Intravenous antispasmodics (hyoscine butylbromide 20mg, Buscopan; Glucagon 
1mg) reduce smooth muscle tone. This potentially flattens folds and has been shown 
to increase the amount of surface area visualised in a CT simulation of colonoscopy. 
Peristalsis is reduced which is recommended by some experts to aid neoplasia 
detection. Use of hyoscine improved polyp detection in a sub group of patients with 
colonic spasm in a randomised study. 
Refs: East JE et al. Gut 2009;58 (Suppl 1);A122, Kiesslich R et al. Gut 2004 ;53:165-7, Lee JM et al. 
Hepatogastroenterology 2010;57:90-4 
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Appendix G 
A hard copy of the training DVD is available at Durham University (via 
Professor Pali Hungin) or upon request from the author. 
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Appendix H 
The Quality Improvement in Colonoscopy (QIC) Study 
Pre-presentation questionnaire 
Date: 
Colonoscopist QIC code: 
 
Please circle the response that you feel is most accurate 
How often do you do/use the following during colonoscopy: 
 
1. Withdraw the scope from caecum to anus in 6 minutes or more? 
 
Always/nearly always Often  Rarely  Never 
 
 
2. Use buscopan for withdrawal? 
 
Always/nearly always Often  Rarely  Never 
 
 
3. Use position change to improve luminal views during withdrawal? 
 
Always/nearly always Often  Rarely  Never 
 
 
4. Retroflex in the rectum? 
 
Always/nearly always Often  Rarely  Never 
 
 
 
 
 
 
Thank You 
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Appendix I 
The Quality Improvement in Colonoscopy (QIC) Study 
Compliance Assessment Form 
Date:      AM or PM list: 
Colonoscopist QIC code:  Number of points: 
 
1. Withdraws scope from caecum to anus in 6 minutes or 
more? (NB: This is assessed in normal colonoscopies only 
where no polyps are removed) 
 
Yes   No 
  
2. Uses buscopan (must be given at caecum at latest)? 
 
Yes   No   
 
If no, was there a contra-indication? 
 
Yes   No  
 
3. Uses supine position for examination of the transverse 
colon during withdrawal? 
 
Yes   No 
 
4. Retroflexes in the rectum? 
 
Yes   No 
 
If no, was there a contra-indication? 
 
Yes   No 
 
 
Thank You  
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Appendix J 
                 
The QIC Study: Preliminary results               
 
Dear [Unit lead(s) name here], 
Here are some preliminary results from the QIC study which I hope you will find interesting. 
XXXXXXXXXXXXXXXXXXXXXXXXXXX Hospital is unit X. The QIC study was presented at the NHS 
Innovations Expo this year as our SHA’s leading project. We would like to take this opportunity to 
thank you on behalf of the study team for your enthusiasm both to date and for the remainder of 
the study.          
 
Best Wishes on behalf of the QIC study team, 
 
 
  
Colin J Rees (NREG Chair)            Praveen Rajasekhar (NREG Fellow)    
 Before After 
Unit No. of 
colons 
PDR 
(Range) 
ADR 
(Range) 
No. of 
colons 
PDR 
(Range) 
ADR 
(Range) 
A 379 23.5 
(0.0-57.1) 
15.3 
(0.0-50.0) 
455 26.4 
(6.3-45.6) 
16.9 
(5.0-29.4) 
B 341 27.0 
(16.1-41.7) 
12.3 
(2.0-27.8) 
547 33.6 
(21.8-39.6) 
18.5 
(10.9-25.0) 
C 525 26.7 
(0.0-51.7) 
18.7 
(0.0-38.5) 
687 30.3 
(0.0-43.3) 
18.3 
(0.0-25.4) 
D 247 28.2 
(0.0-35.7) 
17.6 
(0.0-28.6) 
278 32.7 
(0.0-44.4) 
20.9 
(0.0-44.4) 
E 819 25.4 
(8.8-42.9) 
16.5 
(7.1-31.3) 
972 27.1 
(0.0-53.3) 
15.5 
(0.0-22.0) 
F 267 18.7 
(15.0-33.3) 
10.1 
(5.1-18.8) 
312 21.8 
(17.6-60.0) 
12.2 
(4.3-15.6) 
G 154 39.0 
(26.1-50.0) 
17.5 
(13.0-37.5) 
119 32.8 
(23.3-38.5) 
16.0 
(14.3-23.1) 
H 120 41.7 
(27.1-66.7) 
17.5 
(12.5-23.8) 
266 40.6 
(34.4-47.5) 
17.7 
(15.6-20.3) 
I 275 26.5 
(18.2-39.3) 
12.4 
(0.0-23.3) 
399 27.3 
(13.1-43.3) 
14.8 
(0.0-18.9) 
Tot. 3,124 26.6 
(0.0-66.7) 
15.5 
(0.0-50.0) 
4,035 29.5 
(0.0-60.0) 
16.8 
(0.0-53.3) 
The QIC Study team 
Dr Colin J Rees                 South Tyneside District Hospital 
Dr Matthew D Rutter       University Hospital North Tees 
Dr James E East                 John Radcliffe Hospital, Oxford 
Prof. Mike Bramble                                Durham University 
Dr Brian P Saunders                St. Marks Hospital, London 
Dr Praveen Rajasekhar  South Tyneside District Hospital 
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Appendix K 
 
 Service improvement study.
 Problem
◦ Wide variation in polyp and adenoma detection 
rates.
◦ Operators performance is a factor.
 Design
◦ “Before and after” collaborative cohort study
 Intervention
◦ “Bundle” of 4 evidence based measures
 Outcome measures
1. Uptake of “bundle”.
2. Change in PDR/ADR
 
 14 units within NREG participating.
 Collaborators
◦ Durham University
◦ St. Marks Hospital 
 Funded by an SHA „Good ideas‟ grant.
 Supported by the BSG endoscopy research 
group.
 Department of health have shown support 
for QIC.
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1. Minimal withdrawal time of 6mins
◦ All cases with an intact colon.
2. Routine antispasmodics (buscopan 20mg 
IV)
◦ All cases unless contraindicated when glucagon 
1mg IV may be used
◦ Should be given at caecum at latest 
3. Routine use of supine position for 
transverse colon examination (during 
withdrawal).
4. Routine rectal retroflexion
◦ All cases unless contraindicated
 
1. Change in polyp/adenoma detection 
rate
2. Uptake of the intervention „bundle‟
1. Compliance assessments.
2. Buscopan use.
Data will be analysed on a unit, colonoscopist
(anonymised) and aggregated patient level.
 
Before After
Unit Colons PDR ADR BR Colons PDR 
(Range)
ADR 
(Range)
BR
BAGH 120
41.7
(27.1-66.7)
17.5
(12.5-23.8) 49.2 266
40.6
(34.4-47.5)
17.7
(15.6-20.3) 33.1
DMH 154
39.0
(26.1-50.0)
17.5
(13.0-37.5) 0.6 119
32.8
(23.3-38.5)
16.0
(14.3-23.1) 71.4
UHND 341
27.0
(16.1-41.7)
12.3
(2.0-27.8) 1.2 547
33.6
(21.8-39.6)
18.5
(10.9-25.0) 36.6
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 Compliance assessments
Unit Time  
(%)
Busc. 
(%)
CI
(%)
Position 
(%)
Retro. 
(%)
CI
(%)
N
(%)
BAGH 86.5 91.9 2.7 81.1 94.6 0 13.9
DMH 79.5 95.5 4.5 100 95.5 0 37.0
UHND 75.7 77.1 5.7 92.9 91.4 2 12.8
 
Before After
Unit No. of 
colons
PDR
(Range)
ADR
(Range)
No. of 
colons
PDR
(Range)
ADR
(Range)
A 379 23.5
(0.0-57.1)
15.3
(0.0-50.0)
455 26.4
(6.3-45.6)
16.9
(5.0-29.4)
C 525 26.7
(0.0-51.7)
18.7
(0.0-38.5)
687 30.3
(0.0-43.3)
18.3
(0.0-25.4)
D 247 28.2
(0.0-35.7)
17.6
(0.0-28.6)
278 32.7
(0.0-44.4)
20.9
(0.0-44.4)
E 819 25.4
(8.8-42.9)
16.5
(7.1-31.3)
972 27.1
(0.0-53.3)
15.5
(0.0-22.0)
F 267 18.7
(15.0-33.3)
10.1
(5.1-18.8)
312 21.8
(17.6-60.0)
12.2
(4.3-15.6)
I 275 26.5
(18.2-39.3)
12.4
(0.0-23.3)
399 27.3
(13.1-43.3)
14.8
(0.0-18.9)
J 294 23.2
(12.0-35.5)
14.6
(12.0-19.4)
387 26.6
(5.1-44.6)
17.3
(2.6-23.3)
K 455 27.7
(13.0-50.0)
17.1
(8.7-26.2)
606 33.8
(12.8-53.6)
20.6
(6.4-35.7)
 
 Variable uptake – compliance assessments 
currently being analysed.
 Manoeuvres already being used?
 Possible ceiling affect?
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 There continues to be a variation in PDR/ADR.
 There has been uptake of the intervention 
„bundle‟ but not uniformly.
 Initial data from QIC demonstrates an 
increase in PDR in all units and ADR in 7 out 
of the 11 participating units with „after‟ data.
 
Thanks for you continued 
enthusiasm.
Any questions?
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Appendix L 
Line graphs depicting the direction of movement in ADR of each 
colonoscopist per unit.  
 
Unit A 
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Unit B 
 
 
Unit C 
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Unit D 
 
 
Unit F 
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Unit G 
 
 
Unit H 
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Unit I 
 
 
Unit J 
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Unit K 
 
 
Unit L 
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Appendix M 
Funnel plots demonstrating change in ADR for each colonoscopist with their 
respective unit. 
Unit A 
 
 
 
 
 
 
 
 
 242 
 
Unit B 
 
Unit C 
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Unit D 
 
Unit E 
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Unit F 
 
Unit G 
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Unit H 
 
Unit I 
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Unit J 
 
Unit K 
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Unit L 
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Appendix N 
 
